Submitted URL: http://app.connect.awspls.com/e/er?s=893759278&lid=67898&elqTrackId=3B05944B8DDFA62BC0F097FE7E982BA2&elq=ef35177cf15042e28b702...
Effective URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-c...
Submission: On December 04 via manual from AU

Summary

This website contacted 40 IPs in 6 countries across 36 domains to perform 132 HTTP transactions. The main IP is 3.93.225.3, located in Ashburn, United States and belongs to AMAZON-AES, US. The main domain is www.pharma-iq.com.
TLS certificate: Issued by Amazon on January 28th 2020. Valid for: a year.
This is the only time www.pharma-iq.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 142.0.160.54 7160 (NETDYNAMICS)
1 2 142.0.160.53 7160 (NETDYNAMICS)
5 3.93.225.3 14618 (AMAZON-AES)
1 209.197.3.24 20446 (HIGHWINDS3)
18 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
3 23.111.9.35 33438 (HIGHWINDS2)
1 2a04:4e42:3::621 54113 (FASTLY)
8 104.75.88.112 16625 (AKAMAI-AS)
1 13.35.254.112 16509 (AMAZON-02)
1 172.217.22.66 15169 (GOOGLE)
23 52.217.15.36 16509 (AMAZON-02)
1 54.89.169.13 14618 (AMAZON-AES)
1 2a00:1450:400... 15169 (GOOGLE)
4 216.58.206.2 15169 (GOOGLE)
1 104.111.216.96 16625 (AKAMAI-AS)
2 34.96.102.137 15169 (GOOGLE)
4 13.224.93.127 16509 (AMAZON-02)
2 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
1 2606:4700:303... 13335 (CLOUDFLAR...)
2 2a03:2880:f01... 32934 (FACEBOOK)
1 7 52.48.170.220 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
1 104.103.75.156 16625 (AKAMAI-AS)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
8 2a00:1450:400... 15169 (GOOGLE)
7 2a00:1450:400... 15169 (GOOGLE)
6 3.221.108.253 14618 (AMAZON-AES)
1 13.224.93.116 16509 (AMAZON-02)
1 3.89.179.232 14618 (AMAZON-AES)
1 172.217.18.162 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2 2a05:f500:11:... 14413 (LINKEDIN)
1 1 2620:1ec:21::14 8068 (MICROSOFT...)
1 2 52.19.92.244 16509 (AMAZON-02)
2 2 34.120.207.148 15169 (GOOGLE)
4 4 18.203.78.129 16509 (AMAZON-02)
2 2 52.30.140.199 16509 (AMAZON-02)
1 3.122.214.165 16509 (AMAZON-02)
3 2a03:2880:f11... 32934 (FACEBOOK)
5 2a00:1450:400... 15169 (GOOGLE)
1 52.42.95.19 16509 (AMAZON-02)
132 40
Apex Domain
Subdomains
Transfer
23 amazonaws.com
plsadaptive.s3.amazonaws.com
2 MB
13 doubleclick.net
securepubads.g.doubleclick.net
googleads.g.doubleclick.net
stats.g.doubleclick.net
120 KB
12 googlesyndication.com
pagead2.googlesyndication.com
82fef2a3df2d476b2ff0fa53b76260d0.safeframe.googlesyndication.com
tpc.googlesyndication.com
570 KB
9 google.com
adservice.google.com
www.google.com
2 KB
8 google.de
adservice.google.de
www.google.de
2 KB
8 ml314.com
ml314.com
in.ml314.com
16 KB
8 feathr.co
cdn.feathr.co
polo.feathr.co
marco.feathr.co
polo-v1.feathr.co
37 KB
7 addthis.com
s7.addthis.com
m.addthis.com
api-public.addthis.com
192 KB
5 picreel.com
system.picreel.com
app.picreel.com
25 KB
5 pharma-iq.com
www.pharma-iq.com
485 KB
4 adsrvr.org
match.adsrvr.org
2 KB
3 facebook.com
www.facebook.com
721 B
3 linkedin.com
px.ads.linkedin.com
www.linkedin.com
3 KB
3 fontawesome.com
use.fontawesome.com
107 KB
3 googletagservices.com
www.googletagservices.com
75 KB
2 crwdcntrl.net
sync.crwdcntrl.net
1007 B
2 rlcdn.com
idsync.rlcdn.com
798 B
2 demdex.net
dpm.demdex.net
2 KB
2 google-analytics.com
www.google-analytics.com
19 KB
2 facebook.net
connect.facebook.net
93 KB
2 licdn.com
snap.licdn.com
3 KB
2 visualwebsiteoptimizer.com
dev.visualwebsiteoptimizer.com
2 KB
2 googleadservices.com
www.googleadservices.com
partner.googleadservices.com
13 KB
2 googletagmanager.com
www.googletagmanager.com
38 KB
2 eloqua.com
s893759278.t.eloqua.com
1 KB
1 eyeota.net
ps.eyeota.net
344 B
1 en25.com
img04.en25.com
6 KB
1 addthisedge.com
v1.addthisedge.com
983 B
1 gstatic.com
fonts.gstatic.com
42 KB
1 moatads.com
z.moatads.com
1 KB
1 googleapis.com
fonts.googleapis.com
1 KB
1 iqpc.com
www.iqpc.com
5 KB
1 pcrl.co
assets.pcrl.co
2 KB
1 jsdelivr.net
cdn.jsdelivr.net
4 KB
1 jquery.com
code.jquery.com
24 KB
1 awspls.com
app.connect.awspls.com
663 B
132 36
Domain Requested by
23 plsadaptive.s3.amazonaws.com www.pharma-iq.com
8 www.google.com www.pharma-iq.com
securepubads.g.doubleclick.net
8 googleads.g.doubleclick.net www.googleadservices.com
pagead2.googlesyndication.com
7 www.google.de www.pharma-iq.com
7 ml314.com 1 redirects www.pharma-iq.com
ml314.com
6 pagead2.googlesyndication.com www.pharma-iq.com
pagead2.googlesyndication.com
5 tpc.googlesyndication.com securepubads.g.doubleclick.net
pagead2.googlesyndication.com
tpc.googlesyndication.com
5 polo.feathr.co cdn.feathr.co
www.pharma-iq.com
5 www.pharma-iq.com www.pharma-iq.com
4 match.adsrvr.org 4 redirects
4 system.picreel.com assets.pcrl.co
system.picreel.com
4 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.pharma-iq.com
3 api-public.addthis.com s7.addthis.com
3 www.facebook.com www.pharma-iq.com
connect.facebook.net
3 s7.addthis.com www.pharma-iq.com
s7.addthis.com
3 use.fontawesome.com www.pharma-iq.com
use.fontawesome.com
3 www.googletagservices.com www.pharma-iq.com
pagead2.googlesyndication.com
securepubads.g.doubleclick.net
2 sync.crwdcntrl.net 2 redirects
2 idsync.rlcdn.com 2 redirects
2 dpm.demdex.net 1 redirects www.pharma-iq.com
2 px.ads.linkedin.com 1 redirects www.pharma-iq.com
2 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
2 connect.facebook.net www.pharma-iq.com
connect.facebook.net
2 snap.licdn.com www.pharma-iq.com
snap.licdn.com
2 dev.visualwebsiteoptimizer.com www.pharma-iq.com
2 www.googletagmanager.com www.pharma-iq.com
2 s893759278.t.eloqua.com 1 redirects www.pharma-iq.com
1 app.picreel.com system.picreel.com
1 polo-v1.feathr.co www.pharma-iq.com
1 ps.eyeota.net www.pharma-iq.com
1 www.linkedin.com 1 redirects
1 stats.g.doubleclick.net www.google-analytics.com
1 partner.googleadservices.com pagead2.googlesyndication.com
1 in.ml314.com ml314.com
1 marco.feathr.co www.pharma-iq.com
1 82fef2a3df2d476b2ff0fa53b76260d0.safeframe.googlesyndication.com securepubads.g.doubleclick.net
1 adservice.google.com securepubads.g.doubleclick.net
1 adservice.google.de securepubads.g.doubleclick.net
1 img04.en25.com www.pharma-iq.com
1 m.addthis.com s7.addthis.com
1 v1.addthisedge.com s7.addthis.com
1 fonts.gstatic.com fonts.googleapis.com
1 cdn.feathr.co www.pharma-iq.com
1 z.moatads.com s7.addthis.com
1 fonts.googleapis.com www.pharma-iq.com
1 www.iqpc.com www.pharma-iq.com
1 www.googleadservices.com www.pharma-iq.com
1 assets.pcrl.co www.pharma-iq.com
1 cdn.jsdelivr.net www.pharma-iq.com
1 code.jquery.com www.pharma-iq.com
1 app.connect.awspls.com 1 redirects
132 51
Subject Issuer Validity Valid
pexexchange.com
Amazon
2020-01-28 -
2021-02-28
a year crt.sh
jquery.org
Sectigo RSA Domain Validation Secure Server CA
2020-10-06 -
2021-10-16
a year crt.sh
*.g.doubleclick.net
GTS CA 1O1
2020-11-03 -
2021-01-26
3 months crt.sh
*.google-analytics.com
GTS CA 1O1
2020-11-03 -
2021-01-26
3 months crt.sh
*.fontawesome.com
DigiCert TLS RSA SHA256 2020 CA1
2020-11-13 -
2021-12-14
a year crt.sh
f3.shared.global.fastly.net
GlobalSign CloudSSL CA - SHA256 - G3
2020-10-26 -
2021-04-17
6 months crt.sh
odc-prod-01.oracle.com
DigiCert Secure Site ECC CA-1
2020-07-22 -
2021-10-13
a year crt.sh
assets.pcrl.co
Amazon
2020-07-09 -
2021-08-09
a year crt.sh
www.googleadservices.com
GTS CA 1O1
2020-11-03 -
2021-01-26
3 months crt.sh
*.s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2019-11-09 -
2021-03-12
a year crt.sh
*.iqpc.com
Amazon
2020-11-02 -
2021-12-01
a year crt.sh
upload.video.google.com
GTS CA 1O1
2020-11-03 -
2021-01-26
3 months crt.sh
moatads.com
DigiCert SHA2 Secure Server CA
2020-01-17 -
2021-03-17
a year crt.sh
*.visualwebsiteoptimizer.com
Starfield Secure Certificate Authority - G2
2020-06-19 -
2022-07-06
2 years crt.sh
system.picreel.com
Amazon
2020-01-24 -
2021-02-24
a year crt.sh
*.licdn.com
DigiCert SHA2 Secure Server CA
2019-04-01 -
2021-05-07
2 years crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2020-07-19 -
2021-07-19
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2020-11-02 -
2021-01-30
3 months crt.sh
*.ml314.com
Amazon
2020-02-17 -
2021-03-17
a year crt.sh
*.gstatic.com
GTS CA 1O1
2020-11-03 -
2021-01-26
3 months crt.sh
*.en25.com
DigiCert SHA2 Secure Server CA
2020-08-13 -
2021-11-12
a year crt.sh
*.google.de
GTS CA 1O1
2020-11-03 -
2021-01-26
3 months crt.sh
*.google.com
GTS CA 1O1
2020-11-03 -
2021-01-26
3 months crt.sh
www.google.com
GTS CA 1O1
2020-11-03 -
2021-01-26
3 months crt.sh
www.google.de
GTS CA 1O1
2020-11-03 -
2021-01-26
3 months crt.sh
polo.feathr.co
Let's Encrypt Authority X3
2020-10-26 -
2021-01-24
3 months crt.sh
marco.feathr.co
Amazon
2020-08-22 -
2021-09-22
a year crt.sh
*.googleadservices.com
GTS CA 1O1
2020-11-03 -
2021-01-26
3 months crt.sh
*.t.eloqua.com
DigiCert SHA2 Secure Server CA
2020-03-09 -
2022-04-08
2 years crt.sh
px.ads.linkedin.com
DigiCert SHA2 Secure Server CA
2020-08-05 -
2021-02-05
6 months crt.sh
*.demdex.net
DigiCert SHA2 High Assurance Server CA
2018-01-09 -
2021-02-12
3 years crt.sh
*.eyeota.net
Let's Encrypt Authority X3
2020-10-30 -
2021-01-28
3 months crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2020-11-03 -
2021-01-26
3 months crt.sh
*.picreel.com
Amazon
2020-01-24 -
2021-02-24
a year crt.sh

This page contains 8 frames:

Primary Page: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Frame ID: 85485BA2AE9C1E7AB4DFADDD18004231
Requests: 120 HTTP requests in this frame

Frame: https://s7.addthis.com/static/sh.f48a1a04fe8dbf021b4cda1d.html
Frame ID: 700E1D0CCB2F431FA2D125E78768B231
Requests: 1 HTTP requests in this frame

Frame: https://s7.addthis.com/static/sh.f48a1a04fe8dbf021b4cda1d.html
Frame ID: 71BBE73AC3AC4981F8A243D218D2B8A7
Requests: 1 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/html/r20201201/r20190131/zrt_lookup.html
Frame ID: 9D25392BEDF9E0B91913F5E987DF9B0F
Requests: 1 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?guci=1.2.0.0.2.2.0.0&client=ca-pub-4082781093348003&output=html&adk=1812271804&adf=3025194257&lmt=1607105380&plat=1%3A16809992%2C2%3A32776%2C9%3A32776%2C10%3A32%2C11%3A32%2C16%3A8388608%2C17%3A32%2C24%3A32%2C25%3A32%2C30%3A1081344%2C32%3A32%2C40%3A32&format=0x0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&ea=0&flash=0&pra=5&wgl=1&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d&dt=1607105380633&bpp=13&bdt=837&idt=174&shv=r20201201&cbv=r20190131&ptt=9&saldr=aa&abxe=1&nras=1&correlator=7382961151426&frm=20&pv=2&ga_vid=1574999510.1607105381&ga_sid=1607105381&ga_hid=1119036296&ga_fc=0&u_tz=60&u_his=2&u_java=0&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_nplug=0&u_nmime=0&adx=-12245933&ady=-12245933&biw=1600&bih=1200&scr_x=0&scr_y=0&eid=42530671%2C21066706&oid=3&pvsid=3615357146858264&pem=967&rx=0&eae=2&fc=1920&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C1600%2C1200&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=8192&bc=31&ifi=0&uci=a!0&fsb=1&dtd=190
Frame ID: 1C5657A0DAA0565F0F172C272FF4D134
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuU40b-gg-qsXPxOjoYgiVmd8BVcpy41T7sNx_vN0lZ2moIk14MccYb9WJmMB04VAGZeXzDFYezOv0JcXXgy-klYJMEVfT-Slg7fVhnh4kPWbrjbcaLZR4YwztjFlqXTAi0GEvW5mWE2nre9WJORnhp1omrOv4yV_rViMkNiaazUrTz_K1bJBdgoDzYq5wRw8nKFZeXDi2fuhrxps8Y3fwiFCZfaCILaNettB9w5U_WFXiWvuqLOLCDFt2Z_0h4--eX1HKzPz8EcXkBvvptx-XtyH37xcQI1wtUxBuksd96rZks9-0V9jEly15-tBQkIJK7-pXbBoumk3-ggMhYAB-G-_RuW6jmWDzlF3cDIyVYPH08sxHJosJ1s9qk9Fm5MMCfomjukSZhuWVx2CtaZeMXeDQhu2l6gLSRUifmng8U7XWMJgjljDys6JmZ&sig=Cg0ArKJSzAtC1S66gbpvEAE&adurl=
Frame ID: 855C3EC98DA7A3A9271465838B0006EE
Requests: 9 HTTP requests in this frame

Frame: https://app.picreel.com/api/get_template?source_url=https%253A%252F%252Fwww.pharma-iq.com%252Fpre-clinical-discovery-and-development%252Fwhitepapers%252Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%253Futm_campaign%253DPMIQ-CD-20-12-03%252520PCI%252520WP%252520Launch%2526utm_medium%253Demail%2526utm_source%253Dinternalemail%2526MAC%253D%2526elqContactId%253D32105657%2526disc%253D%2526elqCampId%253D89252%2526utm_content%253DPMIQ-CD-20-12-03%252520PCI%252520WP%252520Launch&source_host=https%253A%252F%252Fwww.pharma-iq.com&templateId=&userAgent=Mozilla%252F5.0%2520(Macintosh%253B%2520Intel%2520Mac%2520OS%2520X%252010_14_5)%2520AppleWebKit%252F537.36%2520(KHTML%252C%2520like%2520Gecko)%2520Chrome%252F83.0.4103.61%2520Safari%252F537.36&referrer=&screenWight=1600&screenHeight=1200&pv=&pp=&sv=&sp=&nv=&np=&rb=&ret=&utm_source=Picreel&utm_medium=display&utm_campaign=Picreel
Frame ID: FBB719E5799D80784FD83A6A868B881D
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/219/runner.html
Frame ID: BD562675554B078BA4915F99C380396A
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. http://app.connect.awspls.com/e/er?s=893759278&lid=67898&elqTrackId=3B05944B8DDFA62BC0F097FE7E982BA2&elq=e... HTTP 302
    https://s893759278.t.eloqua.com/e/er?s=893759278&lid=67898&elqTrackId=3B05944B8DDFA62BC0F097FE7E982BA2&elq=e... HTTP 302
    https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-cli... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Overall confidence: 100%
Detected patterns
  • script /googletagservices\.com\/tag\/js\/gpt(?:_mobile)?\.js/i

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^/]*\/[a-z]*\.js/i

Overall confidence: 100%
Detected patterns
  • script /googlesyndication\.com\//i

Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Overall confidence: 100%
Detected patterns
  • html /<!-- (?:End )?Google Tag Manager -->/i

Overall confidence: 100%
Detected patterns
  • script /jquery[.-]([\d.]*\d)[^/]*\.js/i
  • script /jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?/i

Page Statistics

132
Requests

99 %
HTTPS

41 %
IPv6

36
Domains

51
Subdomains

40
IPs

6
Countries

4362 kB
Transfer

7513 kB
Size

0
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://app.connect.awspls.com/e/er?s=893759278&lid=67898&elqTrackId=3B05944B8DDFA62BC0F097FE7E982BA2&elq=ef35177cf15042e28b7023c70ce00d77&elqaid=103327&elqat=1&utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch HTTP 302
    https://s893759278.t.eloqua.com/e/er?s=893759278&lid=67898&elqTrackId=3B05944B8DDFA62BC0F097FE7E982BA2&elq=ef35177cf15042e28b7023c70ce00d77&elqaid=103327&elqat=1&utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch HTTP 302
    https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 96
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=49766&time=1607105380843&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%20PCI%20WP%20Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26MAC%3D%26utm_content%3DPMIQ-CD-20-12-03%20PCI%20WP%20Launch HTTP 302
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D49766%26time%3D1607105380843%26url%3Dhttps%253A%252F%252Fwww.pharma-iq.com%252Fpre-clinical-discovery-and-development%252Fwhitepapers%252Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%253Futm_campaign%253DPMIQ-CD-20-12-03%2BPCI%2BWP%2BLaunch%2526utm_medium%253Demail%2526utm_source%253Dinternalemail%2526elqContactId%253D32105657%2526disc%253D%2526elqCampId%253D89252%2526MAC%253D%2526utm_content%253DPMIQ-CD-20-12-03%2BPCI%2BWP%2BLaunch%26liSync%3Dtrue HTTP 302
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=49766&time=1607105380843&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03+PCI+WP+Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26MAC%3D%26utm_content%3DPMIQ-CD-20-12-03+PCI+WP+Launch&liSync=true
Request Chain 98
  • https://dpm.demdex.net/ibs:dpid=22052&dpuuid=3615003906035679310&redir= HTTP 302
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=22052&dpuuid=3615003906035679310&redir=
Request Chain 99
  • https://idsync.rlcdn.com/395886.gif?partner_uid=3615003906035679310 HTTP 307
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTMzYxNTAwMzkwNjAzNTY3OTMxMBAAGg0I5Pap_gUSBQjoBxAAQgBKAA HTTP 307
  • https://ml314.com/csync.ashx?fp=5154c2ee2ed80aa92b25c11235bc5da84498f89bc44bcff3b9306cb37da40fa7f4cb09cee1a4f8eb&person_id=3615003906035679310&eid=50082
Request Chain 100
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=d0tro1j&ttd_tpi=1 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=d0tro1j&ttd_tpi=1 HTTP 302
  • https://ml314.com/utsync.ashx?eid=53819&et=0&fp=ae4421a8-03f7-4398-beaa-ce6f993dd862 HTTP 302
  • https://ml314.com/csync.ashx?fp=ae4421a8-03f7-4398-beaa-ce6f993dd862&person_id=3615003906035679310&eid=53819
Request Chain 101
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D3615003906035679310 HTTP 302
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D3615003906035679310 HTTP 302
  • https://ml314.com/csync.ashx?fp=3a78c6be0c0f43665db1f92fe500ca54&eid=50146&person_id=3615003906035679310
Request Chain 122
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=6fgi4r1&ttd_tpi=1&ttd_puid=5fca7b69b0bb6e000780ac18&gdpr=0 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=6fgi4r1&ttd_tpi=1&ttd_puid=5fca7b69b0bb6e000780ac18&gdpr=0 HTTP 302
  • https://polo-v1.feathr.co/v1/analytics/match?f_id=5fca7b69b0bb6e000780ac18&ttd_id=f727f464-6cbf-4d52-b0de-a01511f5b774

132 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market
www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/
Redirect Chain
  • http://app.connect.awspls.com/e/er?s=893759278&lid=67898&elqTrackId=3B05944B8DDFA62BC0F097FE7E982BA2&elq=ef35177cf15042e28b7023c70ce00d77&elqaid=103327&elqat=1&utm_campaign=PMIQ-CD-20-12-03%20PCI%2...
  • https://s893759278.t.eloqua.com/e/er?s=893759278&lid=67898&elqTrackId=3B05944B8DDFA62BC0F097FE7E982BA2&elq=ef35177cf15042e28b7023c70ce00d77&elqaid=103327&elqat=1&utm_campaign=PMIQ-CD-20-12-03%20PCI...
  • https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20La...
182 KB
26 KB
Document
General
Full URL
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.93.225.3 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-93-225-3.compute-1.amazonaws.com
Software
nginx /
Resource Hash
dc9e48e9bac994685b7d539d85650cdd8064937cf8dd6363d50cc526e378022e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.pharma-iq.com
:scheme
https
:path
/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
none
sec-fetch-mode
navigate
sec-fetch-user
?1
sec-fetch-dest
document
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:39 GMT
content-type
text/html; charset=UTF-8
server
nginx
vary
Accept-Encoding
cache-control
no-cache, private
set-cookie
XSRF-TOKEN=eyJpdiI6ImYreEdXSWR5ZEd3b3Y2Ujg0b2gxZnc9PSIsInZhbHVlIjoiVFJ1QjJRa3pSNnY0UHM5WVo3WjlxQW9YcWdneUFxWk80eVJ4dmxwbURpNXRUMG1KS0VcL2t1Q1JhNHhmb1FyWEVUVDFEeEs0RmczWnZGV1ZmaUo5RE93PT0iLCJtYWMiOiIyMzE4M2ZiZTYxMTYxZjI5MmE4YmE1NGEzOWE0ZWNlYzFlOWNlZDlkYjZiZjdjZTA0YmVjNzM1YmFhNzAzOTQ0In0%3D; expires=Fri, 04-Dec-2020 20:09:39 GMT; Max-Age=7200; path=/ ecochannels_eco_app_session=eyJpdiI6Ik9RWk9jblkwZDhTQmRaVDBFTzBPZGc9PSIsInZhbHVlIjoicXBDbE83WGZoXC9rQWlnOWlFb1B0MGVUaTJnYTkrc2ZZOXl3T25GRWNKMG9wK2UrVkU2b3dNYkpxOE1zV3E4RElZZ0lkOFFcL0xVQ1prZ0s5RGF6NjF5QT09IiwibWFjIjoiYTljODg2MjIzMjU0OGIzMzJmOTg1YzdjYjFjZDU1OWFhYjExZGVhN2FkMmU0ZTkwOGRhYjNkOTFkMWExM2NmZCJ9; expires=Fri, 04-Dec-2020 20:09:39 GMT; Max-Age=7200; path=/; httponly channel_id=eyJpdiI6InIzUWQzcmFRZitMbDNjVEtvUTVuYVE9PSIsInZhbHVlIjoiaW5xZlJhNGtPY1lHRkpZMTN5QlowNDE1OGpwRnVOcEZZRGwyVDRReU5CS1h0MXFWWERCSCt4aENtV0l3TmJCUCIsIm1hYyI6IjJhNDJjZmFiMTdjOTI0ZWU2ZjA5M2I0ZjI2NDA2NmI2NmU3YmEyY2IzNWM5YjVjMDA1MjIxYTk0OGM4NDQxZjkifQ%3D%3D; path=/; httponly event_id=eyJpdiI6InoxXC9kRW9sSG9tQ2xIUVkyRzZLVkd3PT0iLCJ2YWx1ZSI6InBBUUdta0Y4MCtvS3l0bWpHYmJ6bHc9PSIsIm1hYyI6ImJhNzM1MzQ2ZjhlYmJiY2NmZjNjZjQ2YjY2NDJjZTM1MWU3Y2VhMDk4MTQ1MTk2Yjg3NWI4NGUxYTFhYjkyOWYifQ%3D%3D; path=/; httponly client_dashboard=eyJpdiI6Im5zVUlwUzRLT3FvXC9IZ3dnNnF5bjJRPT0iLCJ2YWx1ZSI6IkUreDU4T0tDRE0yK3BtaGJ2Nkp1OUE9PSIsIm1hYyI6IjAzZWQ2NjkyOTBhNjVkNWIxMGNlMWRlZTJlODA5OTBiNGEyZDRjNWJmOTZkYjIzZGM2ZjcwNGVkZWZlZDEwNTIifQ%3D%3D; path=/; httponly elq_camp_id=eyJpdiI6IkZ2YXQxNmhzXC9ad0N5UVdrS0NUR0dnPT0iLCJ2YWx1ZSI6InVPZVBzb3JQbWRzVDljelcyZ0RhNXc9PSIsIm1hYyI6ImRjOTU3MzJlZDVjOTFjNWJiYjIwOWI3ZjZkMmUyOTYxZTk2MzBlZDllY2U0MjMxMGU5YTQyNWI3MzkyOTE0NzIifQ%3D%3D; expires=Mon, 04-Jan-2021 04:09:39 GMT; Max-Age=2628000; path=/; httponly utm_campaign=eyJpdiI6IjRJOUMzQVRPb2lFOW43d0pRWHJ4Q2c9PSIsInZhbHVlIjoiWEdZK1RXeTVQb29taU52SFM1VmV3VGNGakdxVjBLc2hldlV3ZEZqdXhOcDgrbXF6YytEbzM0ZzdhVFZscmNCdSIsIm1hYyI6ImRlNTFjOGIxYTU5ZWIwODIwNjlmZDc1Mzk2NGNhYzcxNjM2MDdjOTJlZTAxZTdkZTQ2ODUyZWM3YzNjMzhjNTQifQ%3D%3D; expires=Mon, 04-Jan-2021 04:09:39 GMT; Max-Age=2628000; path=/; httponly utm_source=eyJpdiI6IkRyeHBTckx5Q2FXeGg1a3pZeG1Xd1E9PSIsInZhbHVlIjoiZmtZbVIxQ3N6Wk5UMG5uUXFCclJYbXYrendpWFdTaitEWFdiYjBXUlRCMD0iLCJtYWMiOiIxNTJkM2E2MzIxY2MyZGZlNjcwYTk3MDM3NDVmOTA4Yzc2NTVhODFjZDlmNGQwOWZhY2NjNTNiNTZiZTkxODkzIn0%3D; expires=Mon, 04-Jan-2021 04:09:39 GMT; Max-Age=2628000; path=/; httponly utm_medium=eyJpdiI6IkpSZm0yV2hCbTBOc1pBdHV1OFRaVGc9PSIsInZhbHVlIjoieEFxUFZrdnNuNldTRlRcLzlUVmgwYVE9PSIsIm1hYyI6IjE1YjQ1ZjA0ZGMzZWI0ODQ3NDI4NDVhODVlODg0MzljNmMwYzUyMzg0MGUwZTAzY2Q3NWUwZWJhYjUyNWMyNjQifQ%3D%3D; expires=Mon, 04-Jan-2021 04:09:39 GMT; Max-Age=2628000; path=/; httponly elq_contact_id=eyJpdiI6IjlkMXdtblZ1VUtWR3YyM1hrUHN2dHc9PSIsInZhbHVlIjoiRzBjSzVcL1pqRjNHSVpCRjlzQnZuUnc9PSIsIm1hYyI6ImM2MjM5YTM0ZmJiOGQxOTQ5ZWVmZjZlNWFlMTRjZThkYWNlZTllYjM4YTdmNzU4YjdjOGE5YWI0ODU1YTA3NGYifQ%3D%3D; expires=Mon, 04-Jan-2021 04:09:39 GMT; Max-Age=2628000; path=/; httponly
x-frame-options
SAMEORIGIN
x-xss-protection
1; mode=block
x-content-type-options
nosniff
content-encoding
gzip

Redirect headers

Cache-Control
private,no-store
Pragma
no-cache
Content-Type
text/html; charset=utf-8
Expires
-1
Location
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Set-Cookie
ELOQUA=GUID=2ADCE27DDB584AA4A1F271F9ED6DA0E3; domain=.eloqua.com; expires=Tue, 04-Jan-2022 18:09:38 GMT; path=/;SameSite=None; secure ELQSTATUS=OK; domain=.eloqua.com; expires=Tue, 04-Jan-2022 18:09:38 GMT; path=/;SameSite=None; secure
P3P
CP="IDC DSP COR DEVa TAIa OUR BUS PHY ONL UNI COM NAV CNT STA",
X-Content-Type-Options
nosniff
Date
Fri, 04 Dec 2020 18:09:39 GMT
Content-Length
486
jquery-3.2.1.slim.min.js
code.jquery.com/
68 KB
24 KB
Script
General
Full URL
https://code.jquery.com/jquery-3.2.1.slim.min.js
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
209.197.3.24 Phoenix, United States, ASN20446 (HIGHWINDS3, US),
Reverse DNS
vip0x018.map2.ssl.hwcdn.net
Software
nginx /
Resource Hash
9365920887b11b33a3dc4ba28a0f93951f200341263e3b9cefd384798e4be398

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
last-modified
Mon, 20 Mar 2017 19:01:15 GMT
server
nginx
etag
W/"58d026fb-10fdd"
vary
Accept-Encoding
x-hw
1607105380.dop023.pa1.t,1607105380.cds218.pa1.hn,1607105380.cds228.pa1.c
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=315360000, public
accept-ranges
bytes
content-length
23856
gpt.js
www.googletagservices.com/tag/js/
54 KB
19 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cb9e7a3a041c3882e306beb8a0c7e08c576286f122cfff8fc4a8fc640753587d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"713 / 417 of 1000 / last-modified: 1607083873"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
18644
x-xss-protection
0
expires
Fri, 04 Dec 2020 18:09:39 GMT
js
www.googletagmanager.com/gtag/
96 KB
38 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=UA-3734990-36
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
fa9c75150c2cdf7f681b8a48859ee0d101e242a306a3f09e88f0a1e314702271
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; includeSubDomains
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38720
x-xss-protection
0
expires
Fri, 04 Dec 2020 18:09:40 GMT
app_web.css
www.pharma-iq.com/css/
620 KB
80 KB
Stylesheet
General
Full URL
https://www.pharma-iq.com/css/app_web.css?id=7432dae5dcb1a90be038
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.93.225.3 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-93-225-3.compute-1.amazonaws.com
Software
nginx /
Resource Hash
8dca1487f65966d701ebc1eedcfe70023f69392b50432128fd390b436781e32f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 02 Dec 2020 13:27:51 GMT
server
nginx
etag
W/"5fc79657-9ae6e"
x-frame-options
SAMEORIGIN
content-type
text/css
cache-control
max-age=604800
vary
Accept-Encoding
x-xss-protection
1; mode=block
expires
Fri, 11 Dec 2020 18:09:39 GMT
all.css
use.fontawesome.com/releases/v5.0.10/css/
36 KB
9 KB
Stylesheet
General
Full URL
https://use.fontawesome.com/releases/v5.0.10/css/all.css
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
23.111.9.35 Phoenix, United States, ASN33438 (HIGHWINDS2, US),
Reverse DNS
Software
NetDNA-cache/2.2 /
Resource Hash
cfac6241dd3aabb5f1552c17501790093015c006a8e13671823c1ff4872beaae

Request headers

Origin
https://www.pharma-iq.com
Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:39 GMT
content-encoding
gzip
last-modified
Tue, 10 Apr 2018 23:10:22 GMT
server
NetDNA-cache/2.2
etag
W/"d1acb8ad33b1526acbfd3f0028b859b0"
vary
Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
access-control-allow-methods
GET
content-type
text/css
access-control-allow-origin
*
access-control-max-age
3000
cache-control
max-age=31556926
x-cache
HIT
animate.min.css
cdn.jsdelivr.net/npm/animate.css@3.5.2/
52 KB
4 KB
Stylesheet
General
Full URL
https://cdn.jsdelivr.net/npm/animate.css@3.5.2/animate.min.css
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a04:4e42:3::621 , Ascension Island, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
8fe3fa119255adb5e0c12479331f9e092e85bcff56ab6ecc0510bfa2056b898d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Origin
https://www.pharma-iq.com
Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
age
1309422
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
3958
etag
W/"ce35-l6+hUVafBGsuAfJ8GHFkbpzYfK8"
x-served-by
cache-fra19169-FRA
date
Fri, 04 Dec 2020 18:09:39 GMT
vary
Accept-Encoding
content-type
text/css; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
*
cache-control
public, max-age=31536000, s-maxage=31536000, immutable
accept-ranges
bytes
timing-allow-origin
*
addthis_widget.js
s7.addthis.com/js/300/
353 KB
114 KB
Script
General
Full URL
https://s7.addthis.com/js/300/addthis_widget.js
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.112 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-112.deploy.static.akamaitechnologies.com
Software
nginx/1.15.8 /
Resource Hash
acd2f7ad78edeebad4b6b0fdd17ff57d81c3726c60fd5435ee8c5a0115d29403
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=15724800; includeSubDomains
content-encoding
gzip
last-modified
Mon, 26 Oct 2020 18:11:48 GMT
server
nginx/1.15.8
etag
"5f971164-5834c"
vary
Accept-Encoding
x-distribution
99
content-type
application/javascript
cache-control
public, max-age=600
date
Fri, 04 Dec 2020 18:09:39 GMT
x-host
s7.addthis.com
content-length
116325
jstracker.min.js
assets.pcrl.co/js/
3 KB
2 KB
Script
General
Full URL
https://assets.pcrl.co/js/jstracker.min.js
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
13.35.254.112 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-35-254-112.fra6.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
adf33148613cb07d00c1da3473cf3d7ce89a94c3e2075a065772bcb852f65b71

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
ILWpFNHKyzE1o_od3IQyxMI3qjjCp8cy
Content-Encoding
gzip
ETag
"3b9aad01eeeb35815f6d1641a4650d6c"
Age
13024
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
1356
Last-Modified
Thu, 16 May 2019 15:18:55 GMT
Server
AmazonS3
Date
Fri, 04 Dec 2020 14:32:36 GMT
Content-Type
application/javascript
Via
1.1 d07eabeb1ed60c06da1457f35fb5c8c5.cloudfront.net (CloudFront)
Cache-Control
max-age=21600, must-revalidate
X-Amz-Cf-Pop
FRA6-C1
Accept-Ranges
bytes
X-Amz-Cf-Id
lm63F5Ae7Hs8-Lhv30FkUWHOKoJ4RAI9h7h0AQiP5ytwr8wsctk-Ew==
conversion.js
www.googleadservices.com/pagead/
30 KB
12 KB
Script
General
Full URL
https://www.googleadservices.com/pagead/conversion.js
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.66 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s17-in-f2.1e100.net
Software
cafe /
Resource Hash
09494b789c55d639e0aabeffc59433963f0e8e766baba0fea88eae8a63c40ccd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
11865
x-xss-protection
0
server
cafe
etag
18432201170715473949
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Fri, 04 Dec 2020 18:09:39 GMT
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
133 KB
46 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
4e80da9b66e46d7a664483f6ffd9bf9285ff479ab0393cd81a3582591e30062a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
46825
x-xss-protection
0
server
cafe
etag
16136731290846359922
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Fri, 04 Dec 2020 18:09:40 GMT
pharma-logo-lg_1.png
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
7 KB
7 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/pharma-logo-lg_1.png
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
9f874d0694593e4ad7d03ce4d8ff1151b6f66a65e34d85e012d43d8b144cc0c9

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:41 GMT
Last-Modified
Wed, 21 Nov 2018 19:20:00 GMT
Server
AmazonS3
x-amz-request-id
8Q8J4G1YFKBXCS0M
ETag
"d9eec3d8dc08c0d4398728215ab9be78"
Content-Type
image/png
x-amz-version-id
VF.oQ.LAUuYXNq7byQPsEgLFucbAr3Rg
Accept-Ranges
bytes
Content-Length
6971
x-amz-id-2
p226vY5/irx3hy/EBNpKB3gr/fw4coHkarC+UVUY4BC1H18ujaNKwdHcnXo0FHrCvcCYF/sHyFE=
_i_79d6dc73a1e8694713cca3a6f1dce0bf_PharmaIQ13.jpg
plsadaptive.s3.amazonaws.com/gmedia/jpg/
1 KB
2 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/gmedia/jpg/_i_79d6dc73a1e8694713cca3a6f1dce0bf_PharmaIQ13.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
f49f0e589f35c53229a2e9f57f58694bdcc53d9e3bf3089633285271835ab190

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:41 GMT
Last-Modified
Mon, 23 Nov 2015 00:23:29 GMT
Server
AmazonS3
x-amz-request-id
B56E8C56E82A1BF2
ETag
"946a9d25990f6e4c84f6ade9e6880b71"
Content-Type
image/jpeg
x-amz-version-id
Ssp1IOYyyrRyXzvdSnC6_lKegv6bziyF
Accept-Ranges
bytes
Content-Length
1324
x-amz-id-2
qJ9wKs/D1dT605O8pgyHtRxI1RO4CxdXGho3GF0Eovjsx6NCnFpwlKdy/OnwfKwy1YlLXteX0rk=
how_direct-to-patient_models_can_provide_clinical_supply_chains_with_an_end-to-end_solution_cover.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
112 KB
112 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/how_direct-to-patient_models_can_provide_clinical_supply_chains_with_an_end-to-end_solution_cover.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
12c16af26e0b561443f04c3c9590009bfa2f5d5b1bb2c48fce77ce0d1c10d8d1

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:41 GMT
Last-Modified
Thu, 26 Nov 2020 17:38:23 GMT
Server
AmazonS3
x-amz-request-id
E9C66BA9C2DF7270
ETag
"b69fcf6cffde697b74aae3a2ebf7e723"
x-amz-version-id
G7Qmj8dzPzeD26eVjSjDB2khdErO7t6z
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
114338
x-amz-id-2
cnFzA44ao+/VBOyiZMzEvFJlfEzZd4KFATJKA3nVyH0v/p3I5oN2Ah4IuTm8HTjU6rG71J7DoKk=
Aj22GUdTWUiQpXBdhSz4kMmwcHzpdgTnk6UrSI0g.png
plsadaptive.s3.amazonaws.com/eco/images/logos/
88 KB
88 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/logos/Aj22GUdTWUiQpXBdhSz4kMmwcHzpdgTnk6UrSI0g.png
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
31590958500750c520d2dfc2ee7248ae307f0cbd84e68098fb8d11f9d9161ba7

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:41 GMT
Last-Modified
Fri, 23 Oct 2020 13:17:34 GMT
Server
AmazonS3
x-amz-request-id
B5953956A2383091
ETag
"47ddcc492ae9445891c39a6d8f69824c"
x-amz-version-id
mB6CrEEnPI1Z2F6iKgefrxM9X0MKa6CH
Accept-Ranges
bytes
Content-Type
image/png
Content-Length
89624
x-amz-id-2
iwEtOYLF9wXte69yzSY+8+5J8jlj9ZSH0asvkCMQ86ajrVlt86G909VBuhPoNIdLgmAH6P1It68=
mAd9SDoFt50VaR3zM92PqfCGk8jF96uG3z293qZn.png
plsadaptive.s3.amazonaws.com/eco/images/logos/
1006 KB
1006 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/logos/mAd9SDoFt50VaR3zM92PqfCGk8jF96uG3z293qZn.png
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
ed6795b274957d978ae4ff1bf30c038b02daccd142b322f46d0eb0a30c59c0ad

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:41 GMT
Last-Modified
Mon, 21 May 2018 21:13:51 GMT
Server
AmazonS3
x-amz-request-id
965CA869AE3FB1E6
ETag
"60684ea28d569820ac53cf2c26c0b14c"
Content-Type
image/png
x-amz-version-id
gncrP8VIu8tcqoP4HjlAtRMvOx4OQJoq
Accept-Ranges
bytes
Content-Length
1029707
x-amz-id-2
INaklqyY0SHqwr+wy4Ywap4gbDhSk+rMPE5MUBJ5bpB3b8BqXCvAL2uo5qbBDLPriZiB/y7li/k=
_yxDHM945a5010.jpg
plsadaptive.s3.amazonaws.com/gmedia/
85 KB
86 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/gmedia/_yxDHM945a5010.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
f5193251a1cd99dd8b5f3af531c14e6260614d823cecae22f1a7b62700f915a5

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:41 GMT
Last-Modified
Mon, 05 Jun 2017 14:59:09 GMT
Server
AmazonS3
x-amz-request-id
EDBACE7E47C55442
ETag
"a47ed0fc6181054f042615516c0bcc18"
Content-Type
image/jpeg
x-amz-version-id
jHxavosdEUFqexS8g_6dYfkvrOWGGiGt
Accept-Ranges
bytes
Content-Length
87494
x-amz-id-2
vzG7rjOPo+QXqu26pNdiIah/deWNulluHhdEgm9XcKXiDM/TkH9v4NWKS7E88O0A0DzxWxeiDjE=
_VylMwhome.jpg
plsadaptive.s3.amazonaws.com/gmedia/
145 KB
145 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/gmedia/_VylMwhome.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
cc672427faf8df47a0cc28a737166350e7dddf6add35931b472512a8a97880fa

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:41 GMT
Last-Modified
Tue, 09 Jan 2018 17:31:26 GMT
Server
AmazonS3
x-amz-request-id
0200796179C841A1
ETag
"2cc8d110c28298e2dc056c46c7982727"
Content-Type
image/jpeg
x-amz-version-id
BPFkLJE00iSyYMBD3yaJyzlclijeu61x
Accept-Ranges
bytes
Content-Length
148056
x-amz-id-2
8qFJhRp10O2Gj3cro+3a25MB8igfXv8lMR9VwL7WhKHfaywMHuuKCzQXg0ntC24F+K9nHBXrEOQ=
bKy493u5gLjbFnP4v93V4HuFcYXlaxibbhCDCNrZ.png
plsadaptive.s3.amazonaws.com/eco/images/logos/
137 KB
137 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/logos/bKy493u5gLjbFnP4v93V4HuFcYXlaxibbhCDCNrZ.png
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
db77be7a0c29a01cf4168c987bb92b7a5cc60bcef83b73cb0a41b6372dd7e09f

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:41 GMT
Last-Modified
Wed, 12 Feb 2020 09:12:51 GMT
Server
AmazonS3
x-amz-request-id
D660703F11C39CCF
ETag
"40a134f2eb2434f8a34425a9a6aa9884"
Content-Type
image/png
x-amz-version-id
dOldv5pjY.G6T1VWAOKr6FbsmKuqcI1_
Accept-Ranges
bytes
Content-Length
139964
x-amz-id-2
ncTteYEfq8H9+EC9AwjRYbcksh9tT5InR+lRc+tE1E5XoeMRsAn9ejKMldmQzzWXUtcfAX8cqxo=
lessons_from_covid-19_research_collaboration_what_will_continue_and_what_will_not.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
45 KB
46 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/lessons_from_covid-19_research_collaboration_what_will_continue_and_what_will_not.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
419e35c7b2196bd13f3537da42a20a1dd13478f5772690ffeb3d9f479cdb8196

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:41 GMT
Last-Modified
Thu, 12 Nov 2020 20:44:08 GMT
Server
AmazonS3
x-amz-request-id
82FEE4615AE3CE3A
ETag
"61e7e64cd4342a8a3bce5b8163be95b0"
x-amz-version-id
MXyQ74cCz6lyNrhrFu.uRyl5uw52KWn1
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
46532
x-amz-id-2
vq8ojWNGv/7ZWa2is8P7ZpQN8Ub9sJ7J8ffUqeYU4/3R4ogXDrQOMwLBiiX4/1zQ5zuSCTLopUo=
the_do_s_and_don_ts_of_digital_transformation_lessons_from_the_world_s_top_20_pharma_companies.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
61 KB
61 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/the_do_s_and_don_ts_of_digital_transformation_lessons_from_the_world_s_top_20_pharma_companies.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
102cebc8dcc02dc371917f6e8345381d32076f9ebbda17d964aa95c6f9ed5c7b

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Wed, 28 Oct 2020 16:44:42 GMT
Server
AmazonS3
x-amz-request-id
E5675C56654635B1
ETag
"c46fd675c648909d0379d0ad0d5d0619"
x-amz-version-id
.bXcdr2U9cbjtgCl7MPBA355GGS0Hg7w
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
62426
x-amz-id-2
gZRLkwjp6sVzo6/9DAjp+aQv8//GGr8OBtZDzSzyTH5AxJKiuCVM9nMzk4u1TcL3Ee/nMiUAyCA=
s-clinica_how_biotech_companies_can_improve_clinical_supply_planning_and_distribution.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
77 KB
78 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/s-clinica_how_biotech_companies_can_improve_clinical_supply_planning_and_distribution.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
c4ee93f32892ab779c6c905b51b7c0c8093e1a2009ace11a9c82c599b55d8b75

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Tue, 15 Sep 2020 13:31:23 GMT
Server
AmazonS3
x-amz-request-id
F9BD930CC499502B
ETag
"2821eb4bd1a32ea170b46323ca63f4f1"
x-amz-version-id
4H__hnzasot27NXOdzhgx_oeLi2Tz8Es
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
78912
x-amz-id-2
US8RE+XM7y8Gn7Z7MLhrVD5rhs07wOV9paeZAOH9yTID3RRhCtElAXFq8xBA2tj9sZ4cPkTXUmE=
keeping_tabs_on_covid_19_7.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
47 KB
47 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping_tabs_on_covid_19_7.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
eade44ba267e6d16586276d1a3751ceb3bc3187badd58b2820069a35a260fe44

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Fri, 04 Dec 2020 13:46:25 GMT
Server
AmazonS3
x-amz-request-id
38353E353DDE7ED3
ETag
"9af39d7988a5660bc132e0354d6b3bff"
x-amz-version-id
YPYmmhnpRiNI1w2Ty8zLk5KA_o.evM5O
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
47954
x-amz-id-2
8YZztFb/oBn41IjqbbR8OSL8fBFSxljGaYzsdhjWUhNbu56id1hf5bYKm0O7W3/qSsKf4CGy4SU=
keeping_tabs_on_covid_19_6.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
65 KB
65 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping_tabs_on_covid_19_6.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
301f0362ca2bdd45b8cc82c24e040a4aabdc524c112ed9d47e61bd0f57ab505f

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Thu, 26 Nov 2020 13:17:30 GMT
Server
AmazonS3
x-amz-request-id
E637E2A8A7A7738D
ETag
"41b9daa06fd9fa5ea82eaa1b75e2577c"
x-amz-version-id
7P5dIEkqgJaLGoyj6owR4l42vIJDiae1
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
66597
x-amz-id-2
m2gd3DNrNbpDHf0n9jjBYnSzoXrzU8YIN8E7hpeVYe9o6nlnyqSgQ3c6rAJ7VJp5U1TSSuB2LnU=
keeping_tabs_on_covid_19_5.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
25 KB
26 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping_tabs_on_covid_19_5.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
277477cf714939331d95c46c36c7cea579eaa2a843b428156ce69bceb3ac2c72

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Fri, 20 Nov 2020 15:57:24 GMT
Server
AmazonS3
x-amz-request-id
700DF64916AF4AA8
ETag
"02fa509780057052e900f905876bad09"
x-amz-version-id
HDPUZLJQt54F2HlMryGXgiFRS0AtrTS9
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
25694
x-amz-id-2
vwAKFiJXzQsydRwtWw9es3qk4w4sTdHBrWUzgAJ9jFLdWl+60jK1RtCTS23WD/7+/PXm0ZnLonk=
keeping_tabs_on_covid_19_4.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
79 KB
79 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping_tabs_on_covid_19_4.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
88c79f52657f8536cab77608a2f297f839217e32f5fc220e6556e898673d145d

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Mon, 09 Nov 2020 18:31:23 GMT
Server
AmazonS3
x-amz-request-id
C0BB2287494FAFB1
ETag
"f9757608fb34465d093b4dea5a0f7852"
x-amz-version-id
.IEZaKztG_LITkTqOYG0Pe3jdRPU1A1_
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
80435
x-amz-id-2
hi08WEvnACbnzI6RbOZ+Ysj/r39LQ1txLFNXd7faNB0SKqWz2fVxuMsYEAn10kZiO4w3/55T2/M=
keeping_tabs_on_covid_19_3.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
63 KB
64 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping_tabs_on_covid_19_3.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
473b3db7a9db988ab1404fc50bb594146d886606683758af4c27bb02eabef926

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Sun, 08 Nov 2020 20:08:25 GMT
Server
AmazonS3
x-amz-request-id
8BAB8B8EF4A650CA
ETag
"248c75e4942919e52d443fb20c91a3b7"
x-amz-version-id
JKXrd5uc18DQNMXxJeD3jyWnn5B25ENr
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
64579
x-amz-id-2
7pv5qc16on6u/1VJZDp07HkDeuG3lebmEOjG5mCQACVS8ys1jqfEHYIBicsxescbn6/iFL7UfAw=
keeping_tabs_on_covid-19_4.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
50 KB
50 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping_tabs_on_covid-19_4.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
e532e8e0e759ea2cbd8d88d7ec9b2f8ec588e41b42649a2b0896902052312597

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Fri, 30 Oct 2020 16:05:50 GMT
Server
AmazonS3
x-amz-request-id
B935A1B81E70DB9A
ETag
"ae119addba04a4add5513f3ba28a1422"
x-amz-version-id
3W2tGIs0h5arvPjQeuI.4dww6Uj2Ch7z
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
51108
x-amz-id-2
X4e1SEh23qZIJ7wI7+8MPZTCjV1GrLxXsqbkRm/+CPdtXoHFvk5E6fYRct+ZcY7gEUPdM+80Gfc=
keeping_tabs_on_covid_19_1.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
122 KB
122 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping_tabs_on_covid_19_1.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
595c0e5aadeab1bc5b1ae46ea74414d0cd4df2ab6e7e1d2b92dae6017f1433c5

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Fri, 23 Oct 2020 10:56:11 GMT
Server
AmazonS3
x-amz-request-id
820851E685806DBE
ETag
"0a631290da747d391dde2df218192737"
x-amz-version-id
A3WUKpGFA2CBvuN6HbawUreHSqQMQgZm
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
124778
x-amz-id-2
DVztXC733gz0+a6y/OuSfVK6qprtD6OhAhL/orf361SzXcF/p+LTjXVCxSdeawTrg3bQ9bu9Qmg=
keeping_tabs_on_covid-19_3.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
46 KB
47 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping_tabs_on_covid-19_3.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
2e27117db0e1e4c98a9c4046cabf34116de7bb3a56bf2485dfec2b0422ff50dd

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Fri, 16 Oct 2020 12:05:55 GMT
Server
AmazonS3
x-amz-request-id
1419778DA238B289
ETag
"1c1e675910e919cd66f9ec085541b18b"
x-amz-version-id
Y.nJVeNc0rvqM7pgyaZ6XCxhi2wXqyA3
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
47252
x-amz-id-2
kUmUcdLA5E9J93VNm1Pr4p8nGfug9ggNAhhTxUBVmq8l32SZNA7d2pIgKvgP4QbibQ4LItom814=
keeping-tabs-covid-19_3.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
73 KB
74 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping-tabs-covid-19_3.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
7c621eb075d9a4c3648721285abab71dbe7d6cff26476a561aff1592b465a344

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Fri, 09 Oct 2020 14:02:44 GMT
Server
AmazonS3
x-amz-request-id
B8119D9AEADBCDF8
ETag
"a73e4fc718c9293bb2904506e0772737"
x-amz-version-id
6c6t0eP0850C8gJSb7jRilihZ.V1e34b
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
75073
x-amz-id-2
4ctxuNvBADu3eo7s0+EzLg6Sh7bQa3fuLNfO8fkI9MIYL38rTrBxeyvzzW2taZ5qRsnC+6HxVYo=
keeping_tabs_on_covid_19.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
20 KB
20 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping_tabs_on_covid_19.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
ff5bfe50e28df200278f6d073f91efb63f940f7b0c2ae4041649ec1cb42b3a90

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Fri, 02 Oct 2020 14:17:13 GMT
Server
AmazonS3
x-amz-request-id
DE1380CAF9118667
ETag
"646b235442e51e76c0d64292d00d0ef2"
x-amz-version-id
Ji8ItQpGWT_nbDGFc5512uX9TQ67RtIF
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
20287
x-amz-id-2
Z8Avtan8l1+BBYeInxNh2wYAaLJaIU5napU9Jqcg9lcQUlc9VGRXJI0PSbE6PT+SMunGVU97a7A=
keeping_tabs_covid_19.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
40 KB
40 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping_tabs_covid_19.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
368b229b560c9c81868b28eac823def4da45718c7a3be14e9a8c66322b89675c

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Fri, 25 Sep 2020 15:06:28 GMT
Server
AmazonS3
x-amz-request-id
816C10BB16E8B0A5
ETag
"20cd0ff8224d260ac4b77e73eeb3a2fc"
x-amz-version-id
SQFFqgdfpDrE_crOG5nJP2XJO.78mSPm
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
40765
x-amz-id-2
wT/LMiM4/Skl2tzfM7NLLZdNj3cZ5E3nQcl+wpmN0bt+809hjRQKD2+ART2yK9I+snmMRKeNcsw=
keeping-tabs-covid-19_2.jpg
plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/
71 KB
72 KB
Image
General
Full URL
https://plsadaptive.s3.amazonaws.com/eco/images/channel_content/images/keeping-tabs-covid-19_2.jpg
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.217.15.36 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
c15f742a3ef4232a8d538520ea2c1e36904d1e701313d14bc09fdc54575a9308

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
Date
Fri, 04 Dec 2020 18:09:42 GMT
Last-Modified
Fri, 18 Sep 2020 14:49:29 GMT
Server
AmazonS3
x-amz-request-id
B4C96439853A7D9F
ETag
"e9e14762fffd9536d026913bc5b95a70"
x-amz-version-id
XYvvPPV9hOMIzr8IfFwlMuvrb2ENB1kU
Accept-Ranges
bytes
Content-Type
image/jpeg
Content-Length
73041
x-amz-id-2
ssCg8+vbC5t+SC6l/dB6uHe5NFc8tBtTxTvIHHXJOVlI/PNX1YUfdj4wkgTVn1upyahFmnvr+AI=
iqpc-logo-footer.png
www.iqpc.com/UploadedFiles/EventPage/iqpc_corp/images/
5 KB
5 KB
Image
General
Full URL
https://www.iqpc.com/UploadedFiles/EventPage/iqpc_corp/images/iqpc-logo-footer.png
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.89.169.13 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-89-169-13.compute-1.amazonaws.com
Software
nginx /
Resource Hash
7ca8d8a316355b9f2e92ef77aec435a77f5fa4498af3bed6c876d8f1f774d689
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
last-modified
Tue, 09 May 2017 14:10:46 GMT
server
nginx
etag
"5911cde6-12fc"
x-frame-options
SAMEORIGIN
content-type
image/png
cache-control
max-age=604800
accept-ranges
bytes
content-length
4860
x-xss-protection
1; mode=block
expires
Fri, 11 Dec 2020 18:09:40 GMT
apple_store_icon.png
www.pharma-iq.com/images/
8 KB
8 KB
Image
General
Full URL
https://www.pharma-iq.com/images/apple_store_icon.png
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.93.225.3 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-93-225-3.compute-1.amazonaws.com
Software
nginx /
Resource Hash
9e5c927cf1d06fbdb24bf10daa90e5c6636cf5d43ffabf5a5e1331b2f745adbd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
last-modified
Wed, 02 Dec 2020 13:27:52 GMT
server
nginx
etag
"5fc79658-1edd"
x-frame-options
SAMEORIGIN
content-type
image/png
cache-control
max-age=604800
accept-ranges
bytes
content-length
7901
x-xss-protection
1; mode=block
expires
Fri, 11 Dec 2020 18:09:40 GMT
google_store_icon.png
www.pharma-iq.com/images/
14 KB
14 KB
Image
General
Full URL
https://www.pharma-iq.com/images/google_store_icon.png
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.93.225.3 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-93-225-3.compute-1.amazonaws.com
Software
nginx /
Resource Hash
215e46442382af6784b854e56f70c527d0d205a367c58567c308d3c3fbe31cc2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
last-modified
Wed, 02 Dec 2020 13:27:49 GMT
server
nginx
etag
"5fc79655-3685"
x-frame-options
SAMEORIGIN
content-type
image/png
cache-control
max-age=604800
accept-ranges
bytes
content-length
13957
x-xss-protection
1; mode=block
expires
Fri, 11 Dec 2020 18:09:40 GMT
app_web.js
www.pharma-iq.com/js/
1 MB
357 KB
Script
General
Full URL
https://www.pharma-iq.com/js/app_web.js
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.93.225.3 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-93-225-3.compute-1.amazonaws.com
Software
nginx /
Resource Hash
1b4cdacd97502d37c43f5bdaf301306ef6ab7b6fdb329577b8630dbaaf355e9b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 02 Dec 2020 13:27:49 GMT
server
nginx
etag
W/"5fc79655-1269ec"
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
cache-control
max-age=604800
vary
Accept-Encoding
x-xss-protection
1; mode=block
expires
Fri, 11 Dec 2020 18:09:40 GMT
gtm.js
www.googletagmanager.com/
0
0
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-W92ND8
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

css
fonts.googleapis.com/
11 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Raleway:300,400,500,600,700,800,900
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/css/app_web.css?id=7432dae5dcb1a90be038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
5aaf267d7886b8a29df17fcd871104335cd3f7bbdb15ca67063456f33ad3829d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/css/app_web.css?id=7432dae5dcb1a90be038
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 04 Dec 2020 18:09:40 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
date
Fri, 04 Dec 2020 18:09:40 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
expires
Fri, 04 Dec 2020 18:09:40 GMT
pubads_impl_2020120201.js
securepubads.g.doubleclick.net/gpt/
278 KB
98 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120201.js?21068927
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.206.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s20-in-f2.1e100.net
Software
sffe /
Resource Hash
05512d815f46a3dd0e9aaa163dad6808ea2c7d43c89fe74b821c879c4b1b5046
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 02 Dec 2020 09:38:05 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, immutable, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100031
x-xss-protection
0
expires
Fri, 04 Dec 2020 18:09:40 GMT
moatframe.js
z.moatads.com/addthismoatframe568911941483/
2 KB
1 KB
Script
General
Full URL
https://z.moatads.com/addthismoatframe568911941483/moatframe.js
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.111.216.96 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-216-96.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
05090f9390f5bc0cd23fe5f432037cc92d7cbce1ced9bfe8faf3d1c9abae85cd

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
last-modified
Fri, 08 Nov 2019 20:13:52 GMT
server
AmazonS3
x-amz-request-id
6CDA04CEF72D568E
etag
"f14b4e1f799b14f798a195f43cf58376"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
max-age=60852
accept-ranges
bytes
content-length
948
x-amz-id-2
vmrAbpbzrBs8g4V4M3AoGAqwWb0EhELJ1wy9AWvX/tuPVstbiwgv0ja/UaK2kknp20dNDPCNIa4=
j.php
dev.visualwebsiteoptimizer.com/
3 KB
2 KB
Script
General
Full URL
https://dev.visualwebsiteoptimizer.com/j.php?a=47675&u=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&r=0.34446356603587813
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.96.102.137 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
137.102.96.34.bc.googleusercontent.com
Software
gfra1 /
Resource Hash
0c3dac2832925d623ed61565f92f817608b02cc7a31fc8c968ae9be6a06b65b3

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Dec 2020 18:09:40 GMT
via
1.1 google
server
gfra1
content-encoding
gzip
alt-svc
h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-type
application/javascript; charset=UTF-8
blocked_sites.js
system.picreel.com/js/
281 B
808 B
Script
General
Full URL
https://system.picreel.com/js/blocked_sites.js
Requested by
Host: assets.pcrl.co
URL: https://assets.pcrl.co/js/jstracker.min.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
13.224.93.127 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-93-127.zrh50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
c65aa2b99ceeb0595c8d26af4d026a062fbfae7402667ccd7fa626e43c4f5cbc

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Thu, 03 Dec 2020 20:11:29 GMT
Via
1.1 3a17ea4b3f6bdbc694c3ec0645d21b5e.cloudfront.net (CloudFront)
Last-Modified
Tue, 14 May 2019 05:28:18 GMT
Server
AmazonS3
Age
79092
ETag
"cfe5c6de5d18b2265cc2f986399af585"
X-Cache
Hit from cloudfront
x-amz-version-id
tBnfWhrOfFymnPiDm.89fw0yzvTPUS4E
Connection
keep-alive
X-Amz-Cf-Pop
ZRH50-C1
Accept-Ranges
bytes
Content-Type
application/javascript
Content-Length
281
X-Amz-Cf-Id
9QZxVBBbviyVq7Y1bV3FAU7iZP3YHcKc1vWAuG6zq7bEsCp1uh499g==
insight.min.js
snap.licdn.com/li.lms-analytics/
965 B
761 B
Script
General
Full URL
https://snap.licdn.com/li.lms-analytics/insight.min.js
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:28c::25ea , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
f10b9b0c4107ca5a40a5c69b1ac91a8948d84f39893dee6b429cdbdb05887093

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:40 GMT
Content-Encoding
gzip
Last-Modified
Tue, 22 Sep 2020 22:01:48 GMT
X-CDN
AKAM
Vary
Accept-Encoding
Content-Type
application/x-javascript;charset=utf-8
Cache-Control
max-age=13851
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
448
boomerang.min.js
cdn.feathr.co/js/
114 KB
34 KB
Script
General
Full URL
https://cdn.feathr.co/js/boomerang.min.js
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3033::681c:60b , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
806c9975656fb05571e902f1154303c7b1553ae12444ca54da5b1a150007146c

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"report_to":"cf-nel","max_age":604800}
age
368
x-amz-request-id
D314B7F243CF451A
x-amz-id-2
z3WnY3e1BUu2eLeITsE5O7qhiNU86j5aGVmCVlE9p97lu7PlRV8hpoOmKeiOUxRElozO13H6+h4=
last-modified
Wed, 06 May 2020 17:47:20 GMT
server
cloudflare
etag
W/"360b036656090b581ae5d1ecb2572847"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?s=gGMICWBhkPvw9qwp8zARGJ1VNm19WJzNtjnFfAhNKlPKOVqGF9MExHQLMsLuUcF95ABhK912Jg4fwQpLVZf7bpwsIhy8s7qSEq6iNxm9uzmfngFKZ2jU1O2b"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
cache-control
max-age=14400
cf-request-id
06d08b188300002b599fb4b000000001
cf-ray
5fc77ad40d5f2b59-FRA
/
googleads.g.doubleclick.net/pagead/viewthroughconversion/1051806714/
3 KB
1 KB
Script
General
Full URL
https://googleads.g.doubleclick.net/pagead/viewthroughconversion/1051806714/?random=1607105380336&cv=9&fst=1607105380336&num=1&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&ig=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&hn=www.googleadservices.com&rfmt=3&fmt=4
Requested by
Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
213d27b74239de91866db085833c743515cbf3f6ba902d83a0e9f86afd311da3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
1216
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
googleads.g.doubleclick.net/pagead/viewthroughconversion/1043132011/
3 KB
2 KB
Script
General
Full URL
https://googleads.g.doubleclick.net/pagead/viewthroughconversion/1043132011/?random=1607105380339&cv=9&fst=1607105380336&num=2&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&ig=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&hn=www.googleadservices.com&rfmt=3&fmt=4
Requested by
Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7e6b6f7f6d0a2a471176d91529b3b6da1dd3e8c8601cde5b6d933189cb567f84
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
1218
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
googleads.g.doubleclick.net/pagead/viewthroughconversion/1070947658/
3 KB
1 KB
Script
General
Full URL
https://googleads.g.doubleclick.net/pagead/viewthroughconversion/1070947658/?random=1607105380341&cv=9&fst=1607105380336&num=3&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&ig=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&hn=www.googleadservices.com&rfmt=3&fmt=4
Requested by
Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
956dbd3293c9bb4ea4d1a707c7bb0ce2d393726918594e476066960e447cfb7a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
1218
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
googleads.g.doubleclick.net/pagead/viewthroughconversion/1066919136/
3 KB
1 KB
Script
General
Full URL
https://googleads.g.doubleclick.net/pagead/viewthroughconversion/1066919136/?random=1607105380342&cv=9&fst=1607105380336&num=4&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&ig=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&hn=www.googleadservices.com&rfmt=3&fmt=4
Requested by
Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9a61a80d46405b708b1a1bdb5b0bf7e7bbcebf41cf8d5ffe911dc6a5522bf383
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
1220
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
googleads.g.doubleclick.net/pagead/viewthroughconversion/1070879057/
3 KB
1 KB
Script
General
Full URL
https://googleads.g.doubleclick.net/pagead/viewthroughconversion/1070879057/?random=1607105380343&cv=9&fst=1607105380336&num=5&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&ig=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&hn=www.googleadservices.com&rfmt=3&fmt=4
Requested by
Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
521c2b04940ae77566bdba8a06869e3a449e4ea8058a2f64fc8e0b2c095e82e8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
1220
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
googleads.g.doubleclick.net/pagead/viewthroughconversion/1064507893/
3 KB
2 KB
Script
General
Full URL
https://googleads.g.doubleclick.net/pagead/viewthroughconversion/1064507893/?random=1607105380344&cv=9&fst=1607105380336&num=6&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&ig=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&hn=www.googleadservices.com&rfmt=3&fmt=4
Requested by
Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
70b8a244c85340c5d48ef32544ec5af188923f16e2fe7669fea90782aaf0ad63
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
1218
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
fbevents.js
connect.facebook.net/en_US/
89 KB
24 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
0e49c2b4e86d3fda1dda93eb1210a47712f7b091181b4e7c6da2b3e6f8e86396
Security Headers
Name Value
Content-Security-Policy default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c;
content-encoding
gzip
x-content-type-options
nosniff
alt-svc
h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
23320
x-xss-protection
0
pragma
public
x-fb-debug
iKHNPabKDUVFL1n+q+iCe2jsl1sU+09SrHwogLZCwF/Sh3r3ZGey+9Jwg8Jrp2ChAJ44W+NPIathZ8GJqpnEqw==
x-fb-trip-id
664085054
x-frame-options
DENY
date
Fri, 04 Dec 2020 18:09:40 GMT
strict-transport-security
max-age=31536000; preload; includeSubDomains
content-type
application/x-javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=1200
expires
Sat, 01 Jan 2000 00:00:00 GMT
tag.aspx
ml314.com/
26 KB
12 KB
Script
General
Full URL
https://ml314.com/tag.aspx?4112020
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.48.170.220 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-48-170-220.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
43895ec0a9c63da27834eb87a8f9a63b7810363f7b3f994a526cd2a1b991bd5c

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:39 GMT
Content-Encoding
gzip
Last-Modified
Fri, 04 Dec 2020 17:39:08 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, max-age=84567
Connection
keep-alive
Content-Length
11930
Expires
Sat, 05 Dec 2020 17:39:08 GMT
truncated
/
330 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
793d351cc866196d17887ea6ef5ff0ea5458cb2e88a7e73e92c43ec0dcdb6285

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
1Ptug8zYS_SKggPNyC0IT4ttDfA.woff2
fonts.gstatic.com/s/raleway/v18/
41 KB
42 KB
Font
General
Full URL
https://fonts.gstatic.com/s/raleway/v18/1Ptug8zYS_SKggPNyC0IT4ttDfA.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Raleway:300,400,500,600,700,800,900
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
bb0c201f0ca67e745869967d48db2e90bf01353d1f305959d487291cab6d0755
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.pharma-iq.com
Referer
https://fonts.googleapis.com/css?family=Raleway:300,400,500,600,700,800,900
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 03 Dec 2020 01:58:09 GMT
x-content-type-options
nosniff
last-modified
Wed, 30 Sep 2020 20:45:21 GMT
server
sffe
age
144691
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42444
x-xss-protection
0
expires
Fri, 03 Dec 2021 01:58:09 GMT
fa-solid-900.woff2
use.fontawesome.com/releases/v5.0.10/webfonts/
43 KB
43 KB
Font
General
Full URL
https://use.fontawesome.com/releases/v5.0.10/webfonts/fa-solid-900.woff2
Requested by
Host: use.fontawesome.com
URL: https://use.fontawesome.com/releases/v5.0.10/css/all.css
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
23.111.9.35 Phoenix, United States, ASN33438 (HIGHWINDS2, US),
Reverse DNS
Software
NetDNA-cache/2.2 /
Resource Hash
cb7aa6b06aa5a8eea3670662c4b0c37104041c14575fc170dc48677a0506a33a

Request headers

Origin
https://www.pharma-iq.com
Referer
https://use.fontawesome.com/releases/v5.0.10/css/all.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
last-modified
Tue, 10 Apr 2018 23:10:38 GMT
server
NetDNA-cache/2.2
etag
"84f351b3972185aed620f78489e48b2d"
vary
Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
access-control-allow-methods
GET
content-type
font/woff2
access-control-allow-origin
*
access-control-max-age
3000
cache-control
max-age=31556926
x-cache
HIT
accept-ranges
bytes
content-length
44068
analytics.js
www.google-analytics.com/
46 KB
19 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=UA-3734990-36
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:824::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e441c3e2771625ba05630ab464275136a82c99650ee2145ca5aa9853bedeb01b
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 23 Oct 2020 03:00:57 GMT
server
Golfe2
age
4790
date
Fri, 04 Dec 2020 16:49:50 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
18817
expires
Fri, 04 Dec 2020 18:49:50 GMT
fa-brands-400.woff2
use.fontawesome.com/releases/v5.0.10/webfonts/
54 KB
54 KB
Font
General
Full URL
https://use.fontawesome.com/releases/v5.0.10/webfonts/fa-brands-400.woff2
Requested by
Host: use.fontawesome.com
URL: https://use.fontawesome.com/releases/v5.0.10/css/all.css
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
23.111.9.35 Phoenix, United States, ASN33438 (HIGHWINDS2, US),
Reverse DNS
Software
NetDNA-cache/2.2 /
Resource Hash
e8562087317b34c4b2ac60e28e272b7b33e37523aacd5f2adba7a4f108e415c6

Request headers

Origin
https://www.pharma-iq.com
Referer
https://use.fontawesome.com/releases/v5.0.10/css/all.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
last-modified
Tue, 10 Apr 2018 23:10:32 GMT
server
NetDNA-cache/2.2
etag
"2ac01f7650b5ab76bfebbc708928929e"
vary
Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
access-control-allow-methods
GET
content-type
font/woff2
access-control-allow-origin
*
access-control-max-age
3000
cache-control
max-age=31556926
x-cache
HIT
accept-ranges
bytes
content-length
55144
_ate.track.config_resp
v1.addthisedge.com/live/boost/ra-58c98c10e9fe273b/
3 KB
983 B
Script
General
Full URL
https://v1.addthisedge.com/live/boost/ra-58c98c10e9fe273b/_ate.track.config_resp
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.112 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-112.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
5c329a7f550d3ad4da104c51683286040480bf8e8d1922c7e825df1cd03b8b90

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
etag
1989098345--gzip
vary
Accept-Encoding
content-type
application/javascript;charset=utf-8
cache-control
public, max-age=43, s-maxage=86400
content-disposition
attachment; filename=1.txt
content-length
807
300lo.json
m.addthis.com/live/red_lojson/
89 B
249 B
Script
General
Full URL
https://m.addthis.com/live/red_lojson/300lo.json?si=5fca7b64ceabbd49&bkl=0&bl=1&pdt=1779&sid=5fca7b64ceabbd49&pub=ra-58c98c10e9fe273b&rev=v8.28.8-wp&ln=en&pc=men&cb=0&ab=-&dp=www.pharma-iq.com&fp=pre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market&fr=&of=0&pd=0&irt=0&vcl=0&md=0&ct=1&tct=0&abt=0&cdn=0&pi=1&rb=0&gen=100&chr=UTF-8&colc=1607105380564&jsl=1&uvs=5fca7b646aa2fa58000&skipb=1&callback=addthis.cbs.jsonp__69379224428464760
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.112 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-112.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
ea72e0da51b5c994e02d17fbcccbc9c891bd9ea02af27244ec44e17ee2d880e8

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
cache-control
max-age=0, no-cache, no-store, no-transform
content-disposition
attachment; filename=1.txt
content-length
89
content-type
application/javascript;charset=utf-8
sh.f48a1a04fe8dbf021b4cda1d.html
s7.addthis.com/static/ Frame 700E
0
0

sh.f48a1a04fe8dbf021b4cda1d.html
s7.addthis.com/static/ Frame 71BB
0
0
Document
General
Full URL
https://s7.addthis.com/static/sh.f48a1a04fe8dbf021b4cda1d.html
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.112 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-112.deploy.static.akamaitechnologies.com
Software
nginx/1.15.8 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

:method
GET
:authority
s7.addthis.com
:scheme
https
:path
/static/sh.f48a1a04fe8dbf021b4cda1d.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch

Response headers

server
nginx/1.15.8
content-type
text/html
last-modified
Thu, 04 Jun 2020 15:49:19 GMT
etag
W/"5ed917ff-11adc"
timing-allow-origin
*
cache-control
public, max-age=86313600
p3p
CP="NON ADM OUR DEV IND COM STA"
strict-transport-security
max-age=15724800; includeSubDomains
content-encoding
gzip
content-length
26421
date
Fri, 04 Dec 2020 18:09:40 GMT
vary
Accept-Encoding
x-host
s7.addthis.com
elqCfg.min.js
img04.en25.com/i/
6 KB
6 KB
Script
General
Full URL
https://img04.en25.com/i/elqCfg.min.js
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.103.75.156 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-103-75-156.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
6b4ebd6049c806e3eef1bd770b2d8b4fdd75803861ead3584ee753e41988efae
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
X-Content-Type-Options
nosniff
Last-Modified
Fri, 16 Oct 2020 14:38:37 GMT
ETag
"ee5a418caa3d61:0"
P3P
CP="IDC DSP COR DEVa TAIa OUR BUS PHY ONL UNI COM NAV CNT STA",
Cache-Control
no-cache, no-store
Date
Fri, 04 Dec 2020 18:09:40 GMT
Connection
keep-alive
Accept-Ranges
bytes
Content-Type
application/x-javascript
Content-Length
5943
X-XSS-Protection
1; mode=block
Expires
Fri, 04 Dec 2020 18:09:40 GMT
show_ads_impl_fy2019.js
pagead2.googlesyndication.com/pagead/js/r20201201/r20190131/
234 KB
88 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/r20201201/r20190131/show_ads_impl_fy2019.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
13f17d7843d7a9ee52fffe1b5fe5b01c6783df19cc3d96ca06fc5e506be2849f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
89525
x-xss-protection
0
server
cafe
etag
7078011296875330819
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=1209600
timing-allow-origin
*
expires
Fri, 04 Dec 2020 18:09:40 GMT
zrt_lookup.html
googleads.g.doubleclick.net/pagead/html/r20201201/r20190131/ Frame 9D25
0
0
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/html/r20201201/r20190131/zrt_lookup.html
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
googleads.g.doubleclick.net
:scheme
https
:path
/pagead/html/r20201201/r20190131/zrt_lookup.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
IDE=AHWqTUk9KJqsX6zHmn53-vldXvK9z1xY8TtLN_IhXjUYu365n-fAavY6eyz0I0Xq
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch

Response headers

p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
timing-allow-origin
*
cross-origin-resource-policy
cross-origin
vary
Accept-Encoding
date
Fri, 04 Dec 2020 00:42:37 GMT
expires
Fri, 18 Dec 2020 00:42:37 GMT
content-type
text/html; charset=UTF-8
etag
10723747146953794269
x-content-type-options
nosniff
content-encoding
gzip
server
cafe
content-length
4923
x-xss-protection
0
age
62823
cache-control
public, max-age=1209600
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
v.gif
dev.visualwebsiteoptimizer.com/
35 B
301 B
Image
General
Full URL
https://dev.visualwebsiteoptimizer.com/v.gif?cd=0&a=47675&d=pharma-iq.com&u=D223B3BAF150A2F80185A51057FE65984&h=00acb80b31341598c9d54dc3b171383d&t=false&r=0.4478467364705385
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
34.96.102.137 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
137.102.96.34.bc.googleusercontent.com
Software
gnv1c /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
via
1.1 google
x-content-type-options
nosniff
server
gnv1c
content-type
image/gif
cache-control
private, no-cache, no-cache=Set-Cookie, proxy-revalidate
alt-svc
h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
35
expires
Mon, 10 Jan 2005 00:00:01 GMT
integrator.js
adservice.google.de/adsid/
109 B
803 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.pharma-iq.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120201.js?21068927
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
803 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.pharma-iq.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120201.js?21068927
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
33 KB
13 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3615357146858264&correlator=3477842024051221&output=ldjh&impl=fif&eid=21068927%2C21068809%2C21066706&vrg=2020120201&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201204&iu_parts=22051937397%2Cj.site262.tmus%2Cpre-clinical-discovery-and-development%2Cwhitepapers%2Chow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250&prev_scp=pos%3D1&cookie_enabled=1&bc=31&abxe=1&lmt=1607105380&dt=1607105380729&dlt=1607105379796&idt=890&frm=20&biw=1600&bih=1200&oid=3&adxs=986&adys=1029&adks=1669569689&ucis=1&color_bg=FFFFFF&ifi=1&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&vis=1&dmc=8&scr_x=0&scr_y=0&psz=368x299&msz=368x250&ga_vid=1574999510.1607105381&ga_sid=1607105381&ga_hid=1119036296&fws=0&ohw=0&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120201.js?21068927
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
216.58.206.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s20-in-f2.1e100.net
Software
cafe /
Resource Hash
4913dae29652baeca06eb39c3f1b1bceef90893521dc59b8b1947fd83622f5b0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
12204
x-xss-protection
0
google-lineitem-id
5545247217
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138331863335
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.pharma-iq.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
82fef2a3df2d476b2ff0fa53b76260d0.safeframe.googlesyndication.com/safeframe/1-0-37/html/
0
0
Other
General
Full URL
https://82fef2a3df2d476b2ff0fa53b76260d0.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120201.js?21068927
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

insight.beta.min.js
snap.licdn.com/li.lms-analytics/
4 KB
2 KB
Script
General
Full URL
https://snap.licdn.com/li.lms-analytics/insight.beta.min.js
Requested by
Host: snap.licdn.com
URL: https://snap.licdn.com/li.lms-analytics/insight.min.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:28c::25ea , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
a8431bfe4316cdc20de936e824f735c9478bbc9ce3d3a51c774eca45faff637f

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:40 GMT
Content-Encoding
gzip
Last-Modified
Tue, 22 Sep 2020 22:01:48 GMT
X-CDN
AKAM
Vary
Accept-Encoding
Content-Type
application/x-javascript;charset=utf-8
Cache-Control
max-age=69431
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
1799
/
www.google.com/pagead/1p-user-list/1043132011/
42 B
108 B
Image
General
Full URL
https://www.google.com/pagead/1p-user-list/1043132011/?random=1607105380339&cv=9&fst=1607104800000&num=2&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=944853833&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.de/pagead/1p-user-list/1043132011/
42 B
552 B
Image
General
Full URL
https://www.google.de/pagead/1p-user-list/1043132011/?random=1607105380339&cv=9&fst=1607104800000&num=2&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=944853833&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.com/pagead/1p-user-list/1051806714/
42 B
108 B
Image
General
Full URL
https://www.google.com/pagead/1p-user-list/1051806714/?random=1607105380336&cv=9&fst=1607104800000&num=1&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=3923136569&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.de/pagead/1p-user-list/1051806714/
42 B
108 B
Image
General
Full URL
https://www.google.de/pagead/1p-user-list/1051806714/?random=1607105380336&cv=9&fst=1607104800000&num=1&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=3923136569&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.com/pagead/1p-user-list/1070947658/
42 B
552 B
Image
General
Full URL
https://www.google.com/pagead/1p-user-list/1070947658/?random=1607105380341&cv=9&fst=1607104800000&num=3&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=2252282147&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.de/pagead/1p-user-list/1070947658/
42 B
108 B
Image
General
Full URL
https://www.google.de/pagead/1p-user-list/1070947658/?random=1607105380341&cv=9&fst=1607104800000&num=3&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=2252282147&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.com/pagead/1p-user-list/1070879057/
42 B
108 B
Image
General
Full URL
https://www.google.com/pagead/1p-user-list/1070879057/?random=1607105380343&cv=9&fst=1607104800000&num=5&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=1960747139&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.de/pagead/1p-user-list/1070879057/
42 B
108 B
Image
General
Full URL
https://www.google.de/pagead/1p-user-list/1070879057/?random=1607105380343&cv=9&fst=1607104800000&num=5&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=1960747139&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.com/pagead/1p-user-list/1066919136/
42 B
108 B
Image
General
Full URL
https://www.google.com/pagead/1p-user-list/1066919136/?random=1607105380342&cv=9&fst=1607104800000&num=4&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=2632807647&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.de/pagead/1p-user-list/1066919136/
42 B
66 B
Image
General
Full URL
https://www.google.de/pagead/1p-user-list/1066919136/?random=1607105380342&cv=9&fst=1607104800000&num=4&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=2632807647&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
697992860269740
connect.facebook.net/signals/config/
239 KB
69 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/697992860269740?v=2.9.29&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
0c25573e47923621902b6f4de2ee210dca437878252cc7db83ac4e67d276dc68
Security Headers
Name Value
Content-Security-Policy default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net attachment.fbsbx.com blob: 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net attachment.fbsbx.com blob: 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c;
content-encoding
gzip
x-content-type-options
nosniff
alt-svc
h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
x-xss-protection
0
pragma
public
x-fb-debug
7+6NAdGUVJl3V/GAtpu2gZtN9g3nh+BT0B7OvMLt4wMT6jdxrZVeTjg4aFChkEJqDd+aRubnA4RSrIwLK5LSsQ==
x-fb-trip-id
664085054
x-frame-options
DENY
date
Fri, 04 Dec 2020 18:09:40 GMT
strict-transport-security
max-age=31536000; preload; includeSubDomains
content-type
application/x-javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=1200
x-content-id
1887510331
expires
Sat, 01 Jan 2000 00:00:00 GMT
collect
www.google-analytics.com/j/
2 B
390 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j87&aip=1&a=1119036296&t=pageview&_s=1&dl=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&ul=en-us&de=UTF-8&dt=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=IAhAAUABAAAAAC~&jid=634333030&gjid=51128505&cid=1574999510.1607105381&tid=UA-3734990-36&_gid=1915439653.1607105381&_r=1&gtm=2oub41&z=1470540468
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:824::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.pharma-iq.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
integrations
polo.feathr.co/v1/accounts/5850143e7c1fea34ebb31cca/
42 B
374 B
XHR
General
Full URL
https://polo.feathr.co/v1/accounts/5850143e7c1fea34ebb31cca/integrations
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
faa1444cbae74aad09a3bae4849dd1b0fead937d10b8b79321da628b461f59bd
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:41 GMT
server
nginx/1.17.8
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
content-length
42
refresh
marco.feathr.co/v1/
43 B
585 B
Image
General
Full URL
https://marco.feathr.co/v1/refresh
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
13.224.93.116 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-93-116.zrh50.r.cloudfront.net
Software
/
Resource Hash
98b3d9d20e032f90aca49e9b116225d539ff6fbdb7e42c3c363f63896ac03d2a

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:45 GMT
via
1.1 d92debab8d9ca0518390aebaec8733a7.cloudfront.net (CloudFront)
x-amz-cf-pop
ZRH50-C1
x-amzn-requestid
e109974e-ae13-4d60-a6e4-e46e96404581
access-control-allow-methods
*
content-type
image/gif
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5fca7b69-1fe1882f6b929cf34ad91b8b;Sampled=0
x-cache
Miss from cloudfront
x-amz-apigw-id
XCg4dEXHoAMF_qw=
content-length
43
x-amz-cf-id
9KfM0s_nBIy1UTeDQI0Zg7-85_IyE25qQ2aCoJFne8ACub6ssA_C4g==
access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key
layers.fa6cd1947ce26e890d3d.js
s7.addthis.com/static/
263 KB
76 KB
Script
General
Full URL
https://s7.addthis.com/static/layers.fa6cd1947ce26e890d3d.js
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.112 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-112.deploy.static.akamaitechnologies.com
Software
nginx/1.15.8 /
Resource Hash
6121ca306ad1045453d52517b8f436eb5a68055c82aefa46a9a77de36996a3df
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=15724800; includeSubDomains
content-encoding
gzip
last-modified
Mon, 26 Oct 2020 18:11:48 GMT
server
nginx/1.15.8
etag
W/"5f971164-41cf5"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=86313600
date
Fri, 04 Dec 2020 18:09:40 GMT
x-host
s7.addthis.com
timing-allow-origin
*
content-length
77617
/
www.google.com/pagead/1p-user-list/1064507893/
42 B
530 B
Image
General
Full URL
https://www.google.com/pagead/1p-user-list/1064507893/?random=1607105380344&cv=9&fst=1607104800000&num=6&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=4191915203&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81a::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.de/pagead/1p-user-list/1064507893/
42 B
530 B
Image
General
Full URL
https://www.google.de/pagead/1p-user-list/1064507893/?random=1607105380344&cv=9&fst=1607104800000&num=6&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&sendb=1&frm=0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tiba=How%20direct-to-patient%20clinical%20trial%20models%20can%20accelerate%20speed-to-market%20%7C%20Pharma%20IQ&fmt=3&is_vtc=1&random=4191915203&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
utsync.ashx
ml314.com/
644 B
2 KB
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=82660&ct=js&pi=&fp=&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&pv=1607105380793_030jowinp&bl=en-us&cb=5856458&return=&ht=&d=&dc=&si=1607105380793_030jowinp&cid=Pharma%20IQ-%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market&s=1600x1200&rp=
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?4112020
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.48.170.220 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-48-170-220.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
79b2ab5ce1d39f3e06213a53927ddddb699f6586cf8da17d61e31dc83676768b

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 04 Dec 2020 18:09:40 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
private
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
468
Expires
0
ud.ashx
in.ml314.com/
20 B
482 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=4112020
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?4112020
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.89.179.232 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-89-179-232.compute-1.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:40 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public
Connection
keep-alive
Content-Length
138
Expires
Sat, 05 Dec 2020 18:09:41 GMT
cookie.js
partner.googleadservices.com/gampad/
203 B
643 B
Script
General
Full URL
https://partner.googleadservices.com/gampad/cookie.js?domain=www.pharma-iq.com&callback=_gfp_s_&client=ca-pub-4082781093348003
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/r20201201/r20190131/show_ads_impl_fy2019.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s29-in-f2.1e100.net
Software
cafe /
Resource Hash
03d8c3d1e3dbcbc177edfda02026e31a56f42f6290f35812949c23b1527392b9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
content-type
text/javascript; charset=UTF-8
cache-control
private
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
194
x-xss-protection
0
gen_204
pagead2.googlesyndication.com/pagead/
0
33 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=ach_evt&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&tn=DIV&cls=js-cookie-consent%20cookie-consent&ign=false
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
googleads.g.doubleclick.net/pagead/ Frame 1C56
0
0
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?guci=1.2.0.0.2.2.0.0&client=ca-pub-4082781093348003&output=html&adk=1812271804&adf=3025194257&lmt=1607105380&plat=1%3A16809992%2C2%3A32776%2C9%3A32776%2C10%3A32%2C11%3A32%2C16%3A8388608%2C17%3A32%2C24%3A32%2C25%3A32%2C30%3A1081344%2C32%3A32%2C40%3A32&format=0x0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&ea=0&flash=0&pra=5&wgl=1&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d&dt=1607105380633&bpp=13&bdt=837&idt=174&shv=r20201201&cbv=r20190131&ptt=9&saldr=aa&abxe=1&nras=1&correlator=7382961151426&frm=20&pv=2&ga_vid=1574999510.1607105381&ga_sid=1607105381&ga_hid=1119036296&ga_fc=0&u_tz=60&u_his=2&u_java=0&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_nplug=0&u_nmime=0&adx=-12245933&ady=-12245933&biw=1600&bih=1200&scr_x=0&scr_y=0&eid=42530671%2C21066706&oid=3&pvsid=3615357146858264&pem=967&rx=0&eae=2&fc=1920&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C1600%2C1200&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=8192&bc=31&ifi=0&uci=a!0&fsb=1&dtd=190
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/r20201201/r20190131/show_ads_impl_fy2019.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
googleads.g.doubleclick.net
:scheme
https
:path
/pagead/ads?guci=1.2.0.0.2.2.0.0&client=ca-pub-4082781093348003&output=html&adk=1812271804&adf=3025194257&lmt=1607105380&plat=1%3A16809992%2C2%3A32776%2C9%3A32776%2C10%3A32%2C11%3A32%2C16%3A8388608%2C17%3A32%2C24%3A32%2C25%3A32%2C30%3A1081344%2C32%3A32%2C40%3A32&format=0x0&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&ea=0&flash=0&pra=5&wgl=1&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d&dt=1607105380633&bpp=13&bdt=837&idt=174&shv=r20201201&cbv=r20190131&ptt=9&saldr=aa&abxe=1&nras=1&correlator=7382961151426&frm=20&pv=2&ga_vid=1574999510.1607105381&ga_sid=1607105381&ga_hid=1119036296&ga_fc=0&u_tz=60&u_his=2&u_java=0&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_nplug=0&u_nmime=0&adx=-12245933&ady=-12245933&biw=1600&bih=1200&scr_x=0&scr_y=0&eid=42530671%2C21066706&oid=3&pvsid=3615357146858264&pem=967&rx=0&eae=2&fc=1920&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C1600%2C1200&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=8192&bc=31&ifi=0&uci=a!0&fsb=1&dtd=190
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
IDE=AHWqTUk9KJqsX6zHmn53-vldXvK9z1xY8TtLN_IhXjUYu365n-fAavY6eyz0I0Xq
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch

Response headers

p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
timing-allow-origin
*
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
x-content-type-options
nosniff
content-encoding
br
date
Fri, 04 Dec 2020 18:09:40 GMT
server
cafe
content-length
34
x-xss-protection
0
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
osd.js
www.googletagservices.com/activeview/js/current/
74 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/r20201201/r20190131/show_ads_impl_fy2019.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
69a5b5635e3f65d07c7acd4786ec59d4140d58540aa981b58e0b4319621bd9e8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1606937775260285"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
28382
x-xss-protection
0
expires
Fri, 04 Dec 2020 18:09:40 GMT
svrGP
s893759278.t.eloqua.com/visitor/v200/
49 B
388 B
Image
General
Full URL
https://s893759278.t.eloqua.com/visitor/v200/svrGP?pps=3&siteid=893759278&ref2=elqNone&tzo=-60&ms=832&optin=disabled
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
142.0.160.53 Ashburn, United States, ASN7160 (NETDYNAMICS, US),
Reverse DNS
Software
/
Resource Hash
f1ccea6b7204d9f7913ab45e1afa51d79f83bd4f0319de937b0132e6e02b1aab
Security Headers
Name Value
Strict-Transport-Security max-age=31536000;
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Strict-Transport-Security
max-age=31536000;
X-Content-Type-Options
nosniff
Date
Fri, 04 Dec 2020 18:09:40 GMT
P3P
CP="IDC DSP COR DEVa TAIa OUR BUS PHY ONL UNI COM NAV CNT STA",
Cache-Control
no-store
Content-Type
image/gif
Content-Length
49
X-XSS-Protection
1; mode=block
Expires
-1
collect
stats.g.doubleclick.net/j/
4 B
448 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j87&tid=UA-3734990-36&cid=1574999510.1607105381&jid=634333030&gjid=51128505&_gid=1915439653.1607105381&_u=IAhAAUAAAAAAAC~&z=1295603927
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c09::9b Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
84e01419bd81f32ac6df0f75f49c604fda9172000a3ae432b3c47b2a6a712d80
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Fri, 04 Dec 2020 18:09:40 GMT
content-type
text/plain
access-control-allow-origin
https://www.pharma-iq.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
px.ads.linkedin.com/
Redirect Chain
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=49766&time=1607105380843&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinic...
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D49766%26time%3D1607105380843%26url%3Dhttps%253A%252F%252Fwww.pharma-iq.com%252Fpr...
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=49766&time=1607105380843&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinic...
0
81 B
Image
General
Full URL
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=49766&time=1607105380843&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03+PCI+WP+Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26MAC%3D%26utm_content%3DPMIQ-CD-20-12-03+PCI+WP+Launch&liSync=true
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a05:f500:11:101::b93f:9005 , Ireland, ASN14413 (LINKEDIN, US),
Reverse DNS
Software
Play /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:41 GMT
server
Play
linkedin-action
1
x-li-fabric
prod-lor1
x-li-proto
http/2
x-li-pop
prod-tln1
content-type
application/javascript
content-length
0
x-li-uuid
Q6X4V9SVTRbwLtHzWysAAA==

Redirect headers

content-security-policy
default-src *; connect-src 'self' https://media-src.linkedin.com/media/ www.linkedin.com s.c.lnkd.licdn.com m.c.lnkd.licdn.com s.c.exp1.licdn.com s.c.exp2.licdn.com m.c.exp1.licdn.com m.c.exp2.licdn.com wss://*.linkedin.com dms.licdn.com https://dpm.demdex.net/id lnkd.demdex.net blob: https://accounts.google.com/gsi/status https://linkedin.sc.omtrdc.net/b/ss/ www.google-analytics.com static.licdn.com static-exp1.licdn.com static-exp2.licdn.com static-exp3.licdn.com media.licdn.com media-exp1.licdn.com media-exp2.licdn.com media-exp3.licdn.com; img-src data: blob: *; font-src data: *; style-src 'unsafe-inline' 'self' static-src.linkedin.com *.licdn.com; script-src 'report-sample' 'unsafe-inline' 'unsafe-eval' 'self' spdy.linkedin.com static-src.linkedin.com *.ads.linkedin.com *.licdn.com static.chartbeat.com www.google-analytics.com ssl.google-analytics.com bcvipva02.rightnowtech.com www.bizographics.com sjs.bizographics.com js.bizographics.com d.la4-c1-was.salesforceliveagent.com slideshare.www.linkedin.com https://snap.licdn.com/li.lms-analytics/ platform.linkedin.com platform-akam.linkedin.com platform-ecst.linkedin.com platform-azur.linkedin.com; object-src 'none'; media-src blob: *; child-src blob: lnkd-communities: voyager: *; frame-ancestors 'self'; report-uri https://www.linkedin.com/platform-telemetry/csp?f=l
x-content-type-options
nosniff
linkedin-action
1
content-length
0
x-li-uuid
TSw+UdSVTRbAUUsOaSsAAA==
pragma
no-cache
x-li-pop
afd-prod-lor1
x-msedge-ref
Ref A: B047DE3FFA7740E182415F98CB1DC0CD Ref B: FRAEDGE0722 Ref C: 2020-12-04T18:09:41Z
x-frame-options
sameorigin
date
Fri, 04 Dec 2020 18:09:40 GMT
expect-ct
max-age=86400, report-uri="https://www.linkedin.com/platform-telemetry/ct"
strict-transport-security
max-age=2592000
x-li-fabric
prod-lor1
location
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=49766&time=1607105380843&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03+PCI+WP+Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26MAC%3D%26utm_content%3DPMIQ-CD-20-12-03+PCI+WP+Launch&liSync=true
x-xss-protection
1; mode=block
cache-control
no-cache, no-store
x-li-proto
http/2
expires
Thu, 01 Jan 1970 00:00:00 GMT
jstracker.content.min.js
system.picreel.com/js/
95 KB
22 KB
Script
General
Full URL
https://system.picreel.com/js/jstracker.content.min.js
Requested by
Host: assets.pcrl.co
URL: https://assets.pcrl.co/js/jstracker.min.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
13.224.93.127 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-93-127.zrh50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
6da4b97d617f094ca9c057fa82bd86df862538195ff38fdd30ad08d212afc358

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
cN8jAqOq5_9FbLW50PQYPNUEyDvkCmki
Content-Encoding
gzip
ETag
"94862a47a33a6d45257cbc7ab4af004d"
Age
2323
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
22000
Last-Modified
Wed, 16 Sep 2020 12:57:14 GMT
Server
AmazonS3
Date
Fri, 04 Dec 2020 17:31:39 GMT
Content-Type
application/javascript
Via
1.1 3a17ea4b3f6bdbc694c3ec0645d21b5e.cloudfront.net (CloudFront)
Cache-Control
max-age=21600, must-revalidate
X-Amz-Cf-Pop
ZRH50-C1
Accept-Ranges
bytes
X-Amz-Cf-Id
a8JAkqIuUaIhIORZuR1I-HyzTJNATEa7SsNW-ZFxGHCQVWzvBg7-Jw==
demconf.jpg
dpm.demdex.net/
Redirect Chain
  • https://dpm.demdex.net/ibs:dpid=22052&dpuuid=3615003906035679310&redir=
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=22052&dpuuid=3615003906035679310&redir=
42 B
915 B
Image
General
Full URL
https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=22052&dpuuid=3615003906035679310&redir=
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.19.92.244 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-19-92-244.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

DCS
dcs-prod-irl1-v086-0b5410777.edge-irl1.demdex.com 5.80.1.20201111130852 1ms (+0ms)
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
X-Content-Type-Options
nosniff
X-TID
XFRnGghNSAo=
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Connection
keep-alive
Content-Type
image/gif
Content-Length
42
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
X-TID
ACP2SeQoSes=
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Location
https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=22052&dpuuid=3615003906035679310&redir=
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Connection
keep-alive
Content-Length
0
Expires
Thu, 01 Jan 1970 00:00:00 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://idsync.rlcdn.com/395886.gif?partner_uid=3615003906035679310
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTMzYxNTAwMzkwNjAzNTY3OTMxMBAAGg0I5Pap_gUSBQjoBxAAQgBKAA
  • https://ml314.com/csync.ashx?fp=5154c2ee2ed80aa92b25c11235bc5da84498f89bc44bcff3b9306cb37da40fa7f4cb09cee1a4f8eb&person_id=3615003906035679310&eid=50082
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=5154c2ee2ed80aa92b25c11235bc5da84498f89bc44bcff3b9306cb37da40fa7f4cb09cee1a4f8eb&person_id=3615003906035679310&eid=50082
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.48.170.220 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-48-170-220.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:40 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sat, 05 Dec 2020 13:09:41 GMT

Redirect headers

date
Fri, 04 Dec 2020 18:09:41 GMT
via
1.1 google
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ml314.com/csync.ashx?fp=5154c2ee2ed80aa92b25c11235bc5da84498f89bc44bcff3b9306cb37da40fa7f4cb09cee1a4f8eb&person_id=3615003906035679310&eid=50082
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
clear
content-length
0
csync.ashx
ml314.com/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=d0tro1j&ttd_tpi=1
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=d0tro1j&ttd_tpi=1
  • https://ml314.com/utsync.ashx?eid=53819&et=0&fp=ae4421a8-03f7-4398-beaa-ce6f993dd862
  • https://ml314.com/csync.ashx?fp=ae4421a8-03f7-4398-beaa-ce6f993dd862&person_id=3615003906035679310&eid=53819
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=ae4421a8-03f7-4398-beaa-ce6f993dd862&person_id=3615003906035679310&eid=53819
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.48.170.220 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-48-170-220.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:40 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sat, 05 Dec 2020 13:09:41 GMT

Redirect headers

Pragma
no-cache
Date
Fri, 04 Dec 2020 18:09:40 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Location
https://ml314.com/csync.ashx?fp=ae4421a8-03f7-4398-beaa-ce6f993dd862&person_id=3615003906035679310&eid=53819
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Expires
0,Sat, 05 Dec 2020 13:09:41 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D3615003906035679310
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D3615003906035679310
  • https://ml314.com/csync.ashx?fp=3a78c6be0c0f43665db1f92fe500ca54&eid=50146&person_id=3615003906035679310
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=3a78c6be0c0f43665db1f92fe500ca54&eid=50146&person_id=3615003906035679310
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.48.170.220 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-48-170-220.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:40 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sat, 05 Dec 2020 13:09:41 GMT

Redirect headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:41 GMT
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
location
https://ml314.com/csync.ashx?fp=3a78c6be0c0f43665db1f92fe500ca54&eid=50146&person_id=3615003906035679310
cache-control
no-cache
x-server
10.45.10.150
content-length
0
expires
0
pixel
ps.eyeota.net/
0
344 B
Image
General
Full URL
https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.122.214.165 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-3-122-214-165.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:41 GMT
Content-Length
0
P3P
CP="CURa ADMa DEVa TAIo PSAo PSDo OUR SAMo BUS UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR", policyref="http://ps.eyeota.net/w3c/p3p.xml"
/
www.facebook.com/tr/
44 B
377 B
Image
General
Full URL
https://www.facebook.com/tr/?id=697992860269740&ev=PageView&dl=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&rl=&if=false&ts=1607105380871&sw=1600&sh=1200&v=2.9.29&r=stable&ec=0&o=30&fbp=fb.1.1607105380869.1663367843&it=1607105380747&coo=false&rqm=GET
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:41 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
44
expires
Fri, 04 Dec 2020 18:09:41 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 855C
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuU40b-gg-qsXPxOjoYgiVmd8BVcpy41T7sNx_vN0lZ2moIk14MccYb9WJmMB04VAGZeXzDFYezOv0JcXXgy-klYJMEVfT-Slg7fVhnh4kPWbrjbcaLZR4YwztjFlqXTAi0GEvW5mWE2nre9WJORnhp1omrOv4yV_rViMkNiaazUrTz_K1bJBdgoDzYq5wRw8nKFZeXDi2fuhrxps8Y3fwiFCZfaCILaNettB9w5U_WFXiWvuqLOLCDFt2Z_0h4--eX1HKzPz8EcXkBvvptx-XtyH37xcQI1wtUxBuksd96rZks9-0V9jEly15-tBQkIJK7-pXbBoumk3-ggMhYAB-G-_RuW6jmWDzlF3cDIyVYPH08sxHJosJ1s9qk9Fm5MMCfomjukSZhuWVx2CtaZeMXeDQhu2l6gLSRUifmng8U7XWMJgjljDys6JmZ&sig=Cg0ArKJSzAtC1S66gbpvEAE&adurl=
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
216.58.206.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s20-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201201/r20110914/ Frame 855C
18 KB
8 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201201/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120201.js?21068927
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
dd5620e6f30c9ca43274e1e0a5f9424f97f0dd821a582b22e995586483815392
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 03 Dec 2020 23:29:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
67208
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
7482
x-xss-protection
0
server
cafe
etag
4206736668346422230
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Thu, 17 Dec 2020 23:29:32 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201201/r20110914/client/ Frame 855C
3 KB
2 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201201/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120201.js?21068927
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:820::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f8f96b0cc81405b2a95c412dbf43aebae111f11e98ad743b8fff74b2d5c793a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 16:35:56 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
5625
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1494
x-xss-protection
0
server
cafe
etag
5335486849732140232
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Fri, 18 Dec 2020 16:35:56 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 855C
76 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120201.js?21068927
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
d7f03d75d46816d94b6c288b49a823790aa4a5a6b003e75399ce7be537cc89a9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1606937775260285"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
29365
x-xss-protection
0
expires
Fri, 04 Dec 2020 18:09:40 GMT
l
www.google.com/ads/measurement/ Frame 855C
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQ68nu9hUXaXq3TMUWX04wIy1NdbqzVF9XRcS-eNBPL_ULfcJgVCPgqMM0nebQDuaJKvsZr0aMy_4s8x9PnJuu2mNoddw
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120201.js?21068927
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81a::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

826324003805363652
tpc.googlesyndication.com/simgad/ Frame 855C
413 KB
414 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/826324003805363652
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120201.js?21068927
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f0929ca41f226fe7391ecff67480f4ffd834787df83745e54e473ec2954ab003
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 15:35:15 GMT
x-content-type-options
nosniff
age
9265
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
423295
x-xss-protection
0
last-modified
Wed, 25 Nov 2020 12:49:49 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 04 Dec 2021 15:35:15 GMT
ga-audiences
www.google.com/ads/
42 B
65 B
Image
General
Full URL
https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j87&tid=UA-3734990-36&cid=1574999510.1607105381&jid=634333030&_u=IAhAAUAAAAAAAC~&z=2075097962
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81a::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
65 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j87&tid=UA-3734990-36&cid=1574999510.1607105381&jid=634333030&_u=IAhAAUAAAAAAAC~&z=2075097962
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
shares-post.json
api-public.addthis.com/url/serviceapi/
2 B
346 B
XHR
General
Full URL
https://api-public.addthis.com/url/serviceapi/shares-post.json?services=sFbt&url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.112 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-112.deploy.static.akamaitechnologies.com
Software
nginx/1.15.8 /
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
text/plain

Response headers

strict-transport-security
max-age=15724800; includeSubDomains
surrogate-key
sFbt=https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market
last-modified
Fri, 04 Dec 2020 18:00:00 GMT
server
nginx/1.15.8
date
Fri, 04 Dec 2020 18:09:41 GMT
content-type
application/json
access-control-allow-origin
https://www.pharma-iq.com
cache-control
no-transform, max-age=0, s-maxage=14400
access-control-allow-credentials
true
content-length
2
shares.json
api-public.addthis.com/url/
33 B
370 B
Script
General
Full URL
https://api-public.addthis.com/url/shares.json?url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market&callback=_ate.cbs.rcb_lfkj0
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.112 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-112.deploy.static.akamaitechnologies.com
Software
nginx/1.15.8 /
Resource Hash
b166710f30f269e8d3cd0685bcf1cfdae4df12fd22bf95c868f1d0f135f78bee
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=15724800; includeSubDomains
content-encoding
gzip
surrogate-key
www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market
last-modified
Fri, 04 Dec 2020 18:09:41 GMT
server
nginx/1.15.8
date
Fri, 04 Dec 2020 18:09:41 GMT
vary
Accept-Encoding
content-type
application/json
cache-control
no-transform, must-revalidate, max-age=0, s-maxage=3600
content-length
53
shares.json
api-public.addthis.com/url/
33 B
370 B
Script
General
Full URL
https://api-public.addthis.com/url/shares.json?url=http%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market&callback=_ate.cbs.rcb_713a0
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.112 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-112.deploy.static.akamaitechnologies.com
Software
nginx/1.15.8 /
Resource Hash
f90ebe279bc6e623677ee1be69f3a2606ebdfd02d72f2322f11bf3eef7c9a17e
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=15724800; includeSubDomains
content-encoding
gzip
surrogate-key
www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market
last-modified
Fri, 04 Dec 2020 18:09:41 GMT
server
nginx/1.15.8
date
Fri, 04 Dec 2020 18:09:41 GMT
vary
Accept-Encoding
content-type
application/json
cache-control
no-transform, must-revalidate, max-age=0, s-maxage=3600
content-length
53
truncated
/
443 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5876d235b697479a9e5f476a33115aea1ddc21fd4b4740dd7180398c6224fdba

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
truncated
/ Frame 855C
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9882e32d7d70a05bcdb9cb1c525f3273417ea7452663cd2f823a23bdf32424c0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame 855C
0
45 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssuKprHf4ybz8NwZCbgqU6-Tm-l-BL1VIeu5SFjb1MwSpDUp0MvETuCYIzcr0ueIxWKrcTUcNqCCNhobQ5l3zXCJYP8Z9hESKPpsoizDkL-kOOlAu5arLJzO2SaIS9ps3GcB5gpRq2HgPrhdZFdeDQaGKbBgYqMZmDq10b-q5eaisS7uY1IFyMJ3tjB-C2XEevXJzwkAAJbscUo6-76Xpn1NC_e4n6Y-Qr-jY8SHI-wSBalT9oGiQmnfyU31aFAwu7gzchRmzT6EHE90vb9GtWGwAENuGdpmii02cDrNgUe3aiNbLYqxoaBas8Gye7YtVI7e009m4npaHlK40Wzaqa2_UtZ_G3D-42CLRnsFxjVsHZRgoBwQ5D14UAJenja8Vtf4933o4QbHsIiGq-Ikbzj0zXIDMzy550zRnG6Fd7sPMLOx6rk8yyD59uPbTs&sig=Cg0ArKJSzIzQT6RM9hLMEAE&adurl=
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
216.58.206.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s20-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Dec 2020 18:09:41 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
/
www.facebook.com/tr/
0
85 B
Other
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
multipart/form-data; boundary=----WebKitFormBoundarynSYFrnWJTAaKPKkL

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
server
proxygen-bolt
date
Fri, 04 Dec 2020 18:09:41 GMT
content-type
text/plain
access-control-allow-origin
https://www.pharma-iq.com
access-control-allow-credentials
true
alt-svc
h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
0
activeview
pagead2.googlesyndication.com/pcs/ Frame 855C
42 B
94 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsuAyR1aOCi8NH778a2um0Qp0YAGhBPadGaDgJIX1lPTLAQxiVyJaOgtDDAb0xsabGlLTmvO-ygLGTd6ZgJcc5y_o4oGu-6wXB1ijvbZFuo&sig=Cg0ArKJSzNktfNHVoYEIEAE&adk=1669569689&tt=-1&bs=1600%2C1200&mtos=0,0,1011,1011,1011&tos=0,0,1011,0,0&p=1036,1020,1286,1320&mcvt=1011&rs=3&ht=0&tfs=124&tls=1135&mc=0.65&lte=-1&bas=0&bac=0&met=mue&avms=nio&niot_obs=20&niot_cbk=34&md=2&btr=0&cpmav=0&lm=2&rst=1607105380906&dlt&rpt=125&isd=0&msd=0&xdi=0&postrxl=1&ps=1600%2C3982&scs=1600%2C1200&pt=-1&bin=4&deb=1-0-0-12-5-11-11-0-0-0&tvt=1131&is=300%2C250&iframe_loc=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&r=v&id=osdim&vs=4&uc=12&upc=2&tgt=DIV&cl=1&cec=1&wf=0&cac=1&cd=300x250&itpl=3&v=20201202
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:42 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
script.js
polo.feathr.co/v1/analytics/match/
290 B
565 B
Script
General
Full URL
https://polo.feathr.co/v1/analytics/match/script.js?pk=feathr
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
c44abd8d1919cc3921a847d9c2127f8c6ac2c439430d167dfe65dfe2bf44b241
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:45 GMT
content-encoding
gzip
server
nginx/1.17.8
etag
W/"5fca7b69b0bb6e000780ac18"
vary
Accept-Encoding
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
text/javascript
access-control-allow-origin
*
cache-control
no-cache, max-age=0
access-control-allow-credentials
true
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
pixel.js
polo.feathr.co/v1/accounts/5850143e7c1fea34ebb31cca/
32 B
397 B
Script
General
Full URL
https://polo.feathr.co/v1/accounts/5850143e7c1fea34ebb31cca/pixel.js?pk=feathr
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
eacfa4f711eaca1336ff82619c8a2d310dec11266d594fbc7e5a91259cebf848
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:45 GMT
server
nginx/1.17.8
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
text/javascript
access-control-allow-origin
*
cache-control
must-revalidate, max-age=14400
access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
content-length
32
match
polo-v1.feathr.co/v1/analytics/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=6fgi4r1&ttd_tpi=1&ttd_puid=5fca7b69b0bb6e000780ac18&gdpr=0
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=6fgi4r1&ttd_tpi=1&ttd_puid=5fca7b69b0bb6e000780ac18&gdpr=0
  • https://polo-v1.feathr.co/v1/analytics/match?f_id=5fca7b69b0bb6e000780ac18&ttd_id=f727f464-6cbf-4d52-b0de-a01511f5b774
43 B
402 B
Image
General
Full URL
https://polo-v1.feathr.co/v1/analytics/match?f_id=5fca7b69b0bb6e000780ac18&ttd_id=f727f464-6cbf-4d52-b0de-a01511f5b774
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
98b3d9d20e032f90aca49e9b116225d539ff6fbdb7e42c3c363f63896ac03d2a
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:45 GMT
server
nginx/1.17.8
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
image/gif
access-control-allow-origin
*
cache-control
max-age=0,no-cache,no-store
access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
content-length
43

Redirect headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:45 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://polo-v1.feathr.co/v1/analytics/match?f_id=5fca7b69b0bb6e000780ac18&ttd_id=f727f464-6cbf-4d52-b0de-a01511f5b774
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
267
crumb
polo.feathr.co/v1/analytics/
43 B
402 B
Image
General
Full URL
https://polo.feathr.co/v1/analytics/crumb?cb=1607105385623&a_id=5850143e7c1fea34ebb31cca&f_id=5fca7b69b0bb6e000780ac18&ses_id=5fca7b64a980d1664b286e62&flvr=page_view&loc_url=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&s_w=1600&s_h=1200&b_w=1600&b_h=1200&cust_params=e30=&utm_params=eyJ1dG1fY2FtcGFpZ24iOiJQTUlRLUNELTIwLTEyLTAzJTIwUENJJTIwV1AlMjBMYXVuY2giLCJ1dG1fbWVkaXVtIjoiZW1haWwiLCJ1dG1fc291cmNlIjoiaW50ZXJuYWxlbWFpbCIsInV0bV9jb250ZW50IjoiUE1JUS1DRC0yMC0xMi0wMyUyMFBDSSUyMFdQJTIwTGF1bmNoIn0=
Requested by
Host: www.pharma-iq.com
URL: https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
98b3d9d20e032f90aca49e9b116225d539ff6fbdb7e42c3c363f63896ac03d2a
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:45 GMT
server
nginx/1.17.8
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
image/gif
access-control-allow-origin
*
cache-control
max-age=0,no-cache,no-store
access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
content-length
43
sodar
pagead2.googlesyndication.com/getconfig/
8 KB
7 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20201201&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/r20201201/r20190131/show_ads_impl_fy2019.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
053205d9173cfe75c87b9fb6a335d99b83602ccec6d45df64ad2b71cca2cc3aa
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Dec 2020 18:09:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
6499
x-xss-protection
0
pixel.js
polo.feathr.co/v1/accounts/5850143e7c1fea34ebb31cca/integrations/facebook/
0
319 B
Script
General
Full URL
https://polo.feathr.co/v1/accounts/5850143e7c1fea34ebb31cca/integrations/facebook/pixel.js
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:45 GMT
server
nginx/1.17.8
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
content-length
0
cd.min.js
system.picreel.com/js/
947 B
1 KB
Script
General
Full URL
https://system.picreel.com/js/cd.min.js
Requested by
Host: system.picreel.com
URL: https://system.picreel.com/js/jstracker.content.min.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
13.224.93.127 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-93-127.zrh50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
19307946d5d21a01e4fe16453f2e51b9d7d6226458d5f7de2af9a8bfb127f05d

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
n_c1cIpGEJcZhJ9hIDMWj._AdYJJJMpt
Content-Encoding
gzip
ETag
"6db0367a3eaf0edafdc6fd27eeb4cc14"
Age
1208
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
447
Last-Modified
Tue, 14 May 2019 05:30:06 GMT
Server
AmazonS3
Date
Fri, 04 Dec 2020 17:49:48 GMT
Content-Type
application/javascript
Via
1.1 3a17ea4b3f6bdbc694c3ec0645d21b5e.cloudfront.net (CloudFront)
Cache-Control
max-age=21600, must-revalidate
X-Amz-Cf-Pop
ZRH50-C1
Accept-Ranges
bytes
X-Amz-Cf-Id
bM5k4u9iXrai1QNCbf_GWIrObI8affSES9v12XXHjRz9SfiHu4-VZw==
sodar2.js
tpc.googlesyndication.com/sodar/
16 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/r20201201/r20190131/show_ads_impl_fy2019.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
66bfa6dd42535b06a283b3844a0bddcfd7f1aca1368baae035a7cda89a6b97fd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1603823857801521"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6015
x-xss-protection
0
expires
Fri, 04 Dec 2020 18:09:45 GMT
get_template
app.picreel.com/api/ Frame FBB7
0
0
Document
General
Full URL
https://app.picreel.com/api/get_template?source_url=https%253A%252F%252Fwww.pharma-iq.com%252Fpre-clinical-discovery-and-development%252Fwhitepapers%252Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%253Futm_campaign%253DPMIQ-CD-20-12-03%252520PCI%252520WP%252520Launch%2526utm_medium%253Demail%2526utm_source%253Dinternalemail%2526MAC%253D%2526elqContactId%253D32105657%2526disc%253D%2526elqCampId%253D89252%2526utm_content%253DPMIQ-CD-20-12-03%252520PCI%252520WP%252520Launch&source_host=https%253A%252F%252Fwww.pharma-iq.com&templateId=&userAgent=Mozilla%252F5.0%2520(Macintosh%253B%2520Intel%2520Mac%2520OS%2520X%252010_14_5)%2520AppleWebKit%252F537.36%2520(KHTML%252C%2520like%2520Gecko)%2520Chrome%252F83.0.4103.61%2520Safari%252F537.36&referrer=&screenWight=1600&screenHeight=1200&pv=&pp=&sv=&sp=&nv=&np=&rb=&ret=&utm_source=Picreel&utm_medium=display&utm_campaign=Picreel
Requested by
Host: system.picreel.com
URL: https://system.picreel.com/js/jstracker.content.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.42.95.19 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.4.6 (Ubuntu) / PHP/5.5.9-1ubuntu4.21
Resource Hash

Request headers

Host
app.picreel.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch

Response headers

Content-Encoding
gzip
Content-Type
text/html; charset=utf-8
Date
Fri, 04 Dec 2020 18:15:13 GMT
Server
nginx/1.4.6 (Ubuntu)
X-Powered-By
PHP/5.5.9-1ubuntu4.21
Content-Length
2099
Connection
keep-alive
runner.html
tpc.googlesyndication.com/sodar/sodar2/219/ Frame BD56
0
0
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/219/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:820::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
tpc.googlesyndication.com
:scheme
https
:path
/sodar/sodar2/219/runner.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
content-length
4867
date
Fri, 04 Dec 2020 17:30:51 GMT
expires
Sat, 04 Dec 2021 17:30:51 GMT
last-modified
Mon, 05 Oct 2020 22:33:01 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
2334
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
/
www.facebook.com/tr/
44 B
259 B
Image
General
Full URL
https://www.facebook.com/tr/?id=697992860269740&ev=ViewContent&dl=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&rl=&if=false&ts=1607105385974&cd[b_w]=1600&cd[b_h]=1200&cd[s_w]=1600&cd[s_h]=1200&cd[loc_url]=https%3A%2F%2Fwww.pharma-iq.com%2Fpre-clinical-discovery-and-development%2Fwhitepapers%2Fhow-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market%3Futm_campaign%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch%26utm_medium%3Demail%26utm_source%3Dinternalemail%26MAC%3D%26elqContactId%3D32105657%26disc%3D%26elqCampId%3D89252%26utm_content%3DPMIQ-CD-20-12-03%2520PCI%2520WP%2520Launch&cd[ses_id]=5fca7b64a980d1664b286e62&cd[flvr]=page_view&cd[a_id]=5850143e7c1fea34ebb31cca&cd[debug]=0&cd[bypass_hash]=0&cd[f_id]=5fca7b69b0bb6e000780ac18&sw=1600&sh=1200&v=2.9.29&r=stable&ec=2&o=30&fbp=fb.1.1607105385973.780078016&it=1607105380747&coo=false&rqm=GET
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 04 Dec 2020 18:09:45 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
44
expires
Fri, 04 Dec 2020 18:09:45 GMT
gen_204
pagead2.googlesyndication.com/pagead/
0
46 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar2&v=219&t=2&li=gda_r20201201&jk=3615357146858264&bg=!wcKlwuLNAAXKjztBylhAazk5D6QxAgIAAABMUgAAAAxoAQcKAcbThZowiJULxNQKKkk46HUc8c16AvocwLfi1wKW2Mn5G5jqqEKoPAmr2nP-np-r66gexx8fIojf0FeKDqACt4RIJz6y44Uu7tDtFSk1zQ9N38CFuuCN0a-Q-npCn7Rzi9zkt8_lUO6F5iep5dNUt1aaDfOieNySEAQde2u-1xQxkWn7csGnANzqet7-9Q3aW6Gvj7K8zDKT23GC-R8gpvn3OzlRLrpqS4dyS2Ad3Xa5Lrxy3e8F96-NA3JgTYj1fs0fPtezj8tRl1gUdlPC_lCqfsDQ8q0B1Hn7h1ilYzxTNqCU6O4satM9JXyagdfE-cj3fVKOkLMafnV-bXN-D6N3wt_lHJA2WWJRIWejAdfi6U46wHdOuTxdu5bfyHyh1pcKCVAAjJpgFmHcf0eV_r3geBkMSwtqv4uz3Mnzje5rD629ywqceFK8pSqXdkBnL0J9QgieGatfonbTh5i3rGycxgQWgWi1us2vy1igICkdIgLycvM62lu--fenQmngABbYxLmZxQzA6E1K3kybhDLhU6JUWu49pgVwQmTKzz5JVdfT_eIIHL0nah9-TncOKJ-n2po5XJfyNvisR5D10Bue5zf2Jsw1mQG6NlSwAIievWkD6NbeXDcmnGjYQlQV2vloBjXX6vE1ESLyGi_jqLazcjVsygl5LIAtgviB3yQrUUjZya9xyf7m-6S8c8sHiOoZeIwwn25t3M1D4eE6Efdl9Yz5Lg7tF6ezrWUzBUh8vUSwUbHlsi6KRfpzRzXFioiebfobsAmMZ4CPVTCqi2w2HTAn4fiKIXgVxurRbeL-LSviOtAWijd96T7LIfG2_VilBiJhOaUEFfaTQnG4HpU3ldmQ3BIq38xrdCSdMkjo7XqDtkorVziTQQjXLLzFFQbVh5Z_qbgJnZmIsAAOJgJJXYS1XWHjhissS2dnr4NzajhsOTDmpTAEzhst6WUEfAqDrOJXazBUBctt2Ir4w2RtbBIJFTSeX49-qgw2TZqBZltpJkFz0fPXi5icnhjZrza2qIxY-L3l5D_qNQp-_UYTDbNQ2xG8zfuEdQdL1ruu6SOIOi-jYK5NaLtUktgOsgw3gUDGJOwicfOv097uGsnjxMgZv_LU1G6zFbO8R6y7outgsVVWnbHfUrHFZyYhXfmbkSAvb9yv40beHqV7wu6kWsO1pWw-GCXkjUc6Xhk1k_8iug
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Dec 2020 18:09:46 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
popup-animation.min.css
system.picreel.com/css/
5 KB
1 KB
Stylesheet
General
Full URL
https://system.picreel.com/css/popup-animation.min.css
Requested by
Host: system.picreel.com
URL: https://system.picreel.com/js/jstracker.content.min.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
13.224.93.127 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-93-127.zrh50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
3714c42bcbcfd35aac37a772ae41394db083c72e5b55f239fd443f2a5375c4c6

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
null
Content-Encoding
gzip
ETag
"001ed9b8a194f0db66a97d41a1bedac4"
Age
52425
Transfer-Encoding
chunked
X-Cache
Hit from cloudfront
x-amz-meta-mode
33277
Connection
keep-alive
Last-Modified
Mon, 04 Sep 2017 07:08:00 GMT
Server
AmazonS3
Date
Fri, 04 Dec 2020 03:36:01 GMT
Vary
Accept-Encoding
Content-Type
text/css
Via
1.1 3a17ea4b3f6bdbc694c3ec0645d21b5e.cloudfront.net (CloudFront)
X-Amz-Cf-Pop
ZRH50-C1
X-Amz-Cf-Id
oMxUM9zR6Bv95uLGZ5ivXE6vAS0TvUhhMZL-z1o4wzG7M1HEaa9TVg==
imsync.ashx
ml314.com/
17 B
427 B
Script
General
Full URL
https://ml314.com/imsync.ashx?pi=3615003906035679310&data=eyJwaCI6Mzk3NSwid2giOjEyMDAsInRicyI6MCwiZHQiOjE1LCJwaWQiOiIxNjA3MTA1MzgwNzkzXzAzMGpvd2lucCIsInNkIjoxMjAwfQ%3D%3D
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?4112020
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.48.170.220 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-48-170-220.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
62ce950ad0d7f664b316b4253bbc993bf0bf8310970f64b150fda6f1fa59dfea

Request headers

Referer
https://www.pharma-iq.com/pre-clinical-discovery-and-development/whitepapers/how-direct-to-patient-clinical-trial-models-can-accelerate-speed-to-market?utm_campaign=PMIQ-CD-20-12-03%20PCI%20WP%20Launch&utm_medium=email&utm_source=internalemail&MAC=&elqContactId=32105657&disc=&elqCampId=89252&utm_content=PMIQ-CD-20-12-03%20PCI%20WP%20Launch
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 04 Dec 2020 18:09:55 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
text/html; charset=utf-8
Cache-Control
private
Connection
keep-alive
Content-Length
135

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
s7.addthis.com
URL
https://s7.addthis.com/static/sh.f48a1a04fe8dbf021b4cda1d.html

Verdicts & Comments Add Verdict or Comment

184 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| ontransitionrun object| ontransitionstart object| ontransitioncancel object| cookieStore function| showDirectoryPicker function| showOpenFilePicker function| showSaveFilePicker object| trustedTypes boolean| crossOriginIsolated function| $ function| jQuery object| googletag function| gtag object| dataLayer object| _elqQ object| ggeac object| google_js_reporting_queue object| google_tag_manager function| playDemo function| atwpjp string| _atd function| _euc function| _duc object| _atc string| _atr object| addthis string| addthis_pub function| emdot object| _ate object| _adr object| addthis_conf function| addthis_open function| addthis_close function| addthis_sendto object| _vwo_code number| settings_timer number| _vwo_settings_timer function| isBlockedDomain function| loadScripts function| getParams function| getGetParameters function| getCookie object| linksArray string| link object| get_params boolean| script_loaded boolean| block_loading string| _linkedin_data_partner_id function| feathr function| FeathrBoomerang object| google_conversion_id object| google_custom_params object| google_remarketing_only function| GooglemKTybQhCsO object| google_conversion_date object| google_conversion_time number| google_conversion_snippets number| google_conversion_first_time object| google_conversion_js_version object| google_conversion_format object| google_enable_display_cookie_match object| google_tag_data object| google_conversion_type object| google_conversion_order_id object| google_conversion_language object| google_conversion_value object| google_conversion_currency object| google_conversion_domain object| google_conversion_label object| google_conversion_color object| google_disable_viewthrough object| google_gtag_event_data object| google_conversion_linker object| google_tag_for_child_directed_treatment object| google_tag_for_under_age_of_consent object| google_allow_ad_personalization_signals object| google_restricted_data_processing object| google_conversion_items object| google_conversion_merchant_id object| google_user_id object| onload_callback object| opt_image_generator object| google_gtm_url_processor object| google_conversion_page_url object| google_conversion_referrer_url object| google_gtm object| google_gcl_cookie_prefix object| google_read_gcl_cookie_opt_out object| google_basket_feed_country object| google_basket_feed_language object| google_basket_discount object| google_basket_transaction_type object| google_additional_conversion_params object| google_additional_params object| google_transport_url object| google_gtm_experiments function| fbq function| _fbq object| _ml string| GoogleAnalyticsObject function| ga object| laravelCookieConsent function| setImmediate function| clearImmediate function| Vue function| _ object| summerNote function| emitter function| Pusher object| __core-js_shared__ object| core function| callMessaging object| addthis_share object| addthis_config number| google_srt object| google_ad_modifications object| google_logging_queue boolean| google_measure_js_timing object| google_trust_token_operation_status object| google_reactive_ads_global_state object| adsbygoogle boolean| _gfp_a_ object| google_sa_queue object| google_sl_win function| google_process_slots function| google_spfd object| google_sv_map undefined| b number| _vwo_j_e string| _vwo_mt string| _vwo_tm object| VWO object| vwo_iehack_queue boolean| __@@##MUH function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter object| googleToken object| googleIMState function| processGoogleToken number| __google_ad_urls_id number| google_unique_id object| gaGlobal object| gaplugins object| gaData undefined| feathr_account_id object| __feathrs function| __feathr function| google_sa_impl object| google_persistent_state_async object| __google_ad_urls number| google_global_correlator boolean| _gfp_p_ object| google_image_requests object| google_prev_clients object| google_jobrunner object| ampInaboxIframes object| ampInaboxPendingMessages boolean| google_osd_loaded boolean| google_onload_fired object| _elq function| lintrk boolean| _already_called_lintrk object| blocked_sites boolean| initialized object| _atw string| addthis_exclude boolean| addthis_use_personalization string| addthis_options_default string| addthis_options_rank string| addthis_options object| __callbacks function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb number| len object| picreel object| GoogleGcLKhOms object| PCD

0 Cookies

5 Console Messages

Source Level URL
Text
console-api warning URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120201.js?21068927(Line 6)
Message:
GPT synchronous rendering is no longer supported, ads will be requested and rendered asynchronously. See https://support.google.com/admanager/answer/9212594 for more details.
console-api log URL: https://system.picreel.com/js/jstracker.content.min.js(Line 1)
Message:
remove_prev_reminderbar 0
console-api log URL: https://system.picreel.com/js/jstracker.content.min.js(Line 1)
Message:
init: isReminderbarPassed false
console-api log URL: https://system.picreel.com/js/jstracker.content.min.js(Line 1)
Message:
init: connectedReminderbarTemplateId
console-api log URL: https://system.picreel.com/js/jstracker.content.min.js(Line 1)
Message:
init: isOnlyReminderbarTrigger false

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

82fef2a3df2d476b2ff0fa53b76260d0.safeframe.googlesyndication.com
adservice.google.com
adservice.google.de
api-public.addthis.com
app.connect.awspls.com
app.picreel.com
assets.pcrl.co
cdn.feathr.co
cdn.jsdelivr.net
code.jquery.com
connect.facebook.net
dev.visualwebsiteoptimizer.com
dpm.demdex.net
fonts.googleapis.com
fonts.gstatic.com
googleads.g.doubleclick.net
idsync.rlcdn.com
img04.en25.com
in.ml314.com
m.addthis.com
marco.feathr.co
match.adsrvr.org
ml314.com
pagead2.googlesyndication.com
partner.googleadservices.com
plsadaptive.s3.amazonaws.com
polo-v1.feathr.co
polo.feathr.co
ps.eyeota.net
px.ads.linkedin.com
s7.addthis.com
s893759278.t.eloqua.com
securepubads.g.doubleclick.net
snap.licdn.com
stats.g.doubleclick.net
sync.crwdcntrl.net
system.picreel.com
tpc.googlesyndication.com
use.fontawesome.com
v1.addthisedge.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googleadservices.com
www.googletagmanager.com
www.googletagservices.com
www.iqpc.com
www.linkedin.com
www.pharma-iq.com
z.moatads.com
s7.addthis.com
104.103.75.156
104.111.216.96
104.75.88.112
13.224.93.116
13.224.93.127
13.35.254.112
142.0.160.53
142.0.160.54
172.217.18.162
172.217.22.66
18.203.78.129
209.197.3.24
216.58.206.2
23.111.9.35
2606:4700:3033::681c:60b
2620:1ec:21::14
2a00:1450:4001:806::2008
2a00:1450:4001:80b::2001
2a00:1450:4001:819::2002
2a00:1450:4001:819::2003
2a00:1450:4001:81a::2004
2a00:1450:4001:81d::2003
2a00:1450:4001:81e::2002
2a00:1450:4001:820::2001
2a00:1450:4001:820::200a
2a00:1450:4001:824::200e
2a00:1450:400c:c09::9b
2a02:26f0:6c00:28c::25ea
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8183:face:b00c:0:25de
2a04:4e42:3::621
2a05:f500:11:101::b93f:9005
3.122.214.165
3.221.108.253
3.89.179.232
3.93.225.3
34.120.207.148
34.96.102.137
52.19.92.244
52.217.15.36
52.30.140.199
52.42.95.19
52.48.170.220
54.89.169.13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